Profil global d'abrema
L’Autorité Burundaise de Régulation des Médicaments à usage humain et des Aliments « ABREMA » en sigle, est une administration personnalisée de l’Etat placée sous la tutelle du ministère ayant la santé publique dans ses attributions. L’ABREMA est régie par la loi N°1/11 du 08 Mai 2020 portant Réglementation de l’exercice de la Pharmacie et du Médicament à usage humain, et a été créé en 2021 par le décret N° 100/039 du 26 Février 2021 portant création, organisation et fonctionnement de l’Autorité Burundaise de Régulation des Médicaments à usage humain et des Aliments « ABREMA ». L’ABREMA a pour objectif général de protéger la santé publique par la promotion de la qualité et la sécurité sanitaire des produits tels que les aliments préfabriqués et emballés, les médicaments à usage humain, les produits cosmétiques et diététiques contenant un principe actif, les médicaments à base de plantes, les médicaments traditionnels, les dispositifs médicaux ou les matériaux ou substances utilisés dans la fabrication des produits dont la consommation ou l’utilisation peut nuire à la santé humaine.
Produits enregistrés
| # | DESIGNATION COMMERCIALE | DCI | DOSAGE | FORME | CONDITIONNEMENT | CATEGORIE | NOM LABO FABRICANT | PAYS ORIGINE | TITULAIRE AMM | PAYS TITULAIRE AMM | No ENREGISTREMENT | DATE ENREGISTREMENT | STATUT AMM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TETRAREN | Tetracycline HCl | 250 mg | Capsule | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-561N/2020 | 2020-12-01 | VALIDE |
| 2 | REPRAZINE | Chlorpromazine hydrochloride | 100 mg | Comprimé | B/10 x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-560N/2020 | 2020-12-01 | VALIDE |
| 3 | RENETRIM DS | Sulfamethoxazole Trimethoprime | 800 mg 160 mg | Comprimé | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-559N/2020 | 2020-12-01 | VALIDE |
| 4 | RENESTEN-V | Clotrimazole | 100 mg | Ovule | B/6 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-558N/2020 | 2020-12-01 | VALIDE |
| 5 | RENE HAND SANITIZER | Ethanol | 0.8 | Solution | FL/500 ml | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-557N/2020 | 2020-12-01 | VALIDE |
| 6 | POVIREN | Povidone Iode | 0.1 | Solution topique | FL/200 ml | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-556N/2020 | 2020-12-01 | VALIDE |
| 7 | PENIREN | Phenoxymethylpenicilline Potassium | 250 mg | Comprimé | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-555N/2020 | 2020-12-01 | VALIDE |
| 8 | NITROREN | Nitrofurantoine | 100 mg | Comprimé | B/10 x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-554N/2020 | 2020-12-01 | VALIDE |
| 9 | FOLIC ACID | Acide folique | 5 mg | Comprimé | B/10 x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-553N/2020 | 2020-12-01 | VALIDE |
| 10 | FLUZOLE | Fluconazole | 200 mg | Capsule | B/4 et B/5 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-552N/2020 | 2020-12-01 | VALIDE |
| 11 | DOXYREN | Doxycycline | 100 mg | Capsule | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-551N/2020 | 2020-12-01 | VALIDE |
| 12 | DERMOREN | Griséofulvine | 500 mg | Comprimé | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-550N/2020 | 2020-12-01 | VALIDE |
| 13 | CLOXAREN | Cloxacilline de Sodium | 250 mg | Capsule | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-549N/2020 | 2020-12-01 | VALIDE |
| 14 | BECOREN | Vitamine B1 Mononitrate Vitamin B2 Vitamine B6 Ni | 0,5 mg 0,5 mg 0,5 mg 7,5 mg | Comprimé | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Germany | MSPLS-DPML-548N/2020 | 2020-12-01 | VALIDE |
| 15 | AMCLOREN | Ampicilline Trihydrate Cloxacilline Sodium | 125 mg 125 mg | Poudre pour suspension buvable | Flacon /100 ml | Générique | Rene Industries Ltd | Germany | Rene Industries Ltd | Germany | MSPLS-DPML-547N/2020 | 2020-12-01 | VALIDE |
| 16 | Zolendro-Denk 4 mg/5 ml | Acide zoledronique | 4 mg/5ml | Solution à diluer pour perfusion | Flacon de 5 ml | Génerique | Siegfried Hameln GmbH | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-546N/2020 | 2020-12-01 | VALIDE |
| 17 | Tramadol Denk 50 | Chlorhydrate de Tramadol | 50 mg | Comprimé effervescent | B/10 | Génerique | Losan Pharma GmbH | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-545N/2020 | 2020-12-01 | VALIDE |
| 18 | ParaCo-Denk 1000/60 | Paracétamol Codéine phosphate hémihydrate | 1000 mg 60 mg | Suppositoire | B/10 | Génerique | bene Arzneimittel GmbH | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-544N/2020 | 2020-12-01 | VALIDE |
| 19 | ParaCo-Denk 500/30 | Paracétamol Codéine phosphate hémihydrate | 500 mg 30 mg | Comprimé | B/20 | Génerique | bene Arzneimittel GmbH | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-543N/2020 | 2020-12-01 | VALIDE |
| 20 | Panto-Denk 40 | Pantoprazole | 40mg | Comprimé | B/28 | Génerique | DENK PHARMA GmbH & Co. KG | Germany | DENK PHARMA GmbH & Co. KG | Germany | MSPLS-DPML-542N/2020 | 2020-12-01 | VALIDE |
| 21 | Losar-Denk 100 | Losartan potassique | 100 mg | Comprimé pelliculé | B/28 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-541N/2020 | 2020-12-01 | VALIDE |
| 22 | Flucona-Denk150 | Fluconazole | 150 mg | Gélule | B/1 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-540N/2020 | 2020-12-01 | VALIDE |
| 23 | Flucona-Denk 100 | Fluconazole | 100 mg | Gélule | B/10 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-539N/2020 | 2020-12-01 | VALIDE |
| 24 | Doxy-Denk 200 | Doxycycline hydrate | 200 mg | Comprimé pelliculé | B/8 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-538N/2020 | 2020-12-01 | VALIDE |
| 25 | Doxy-Denk 100 | Doxycycline hydrate | 100 mg | Comprimé | B/20 | Génerique | Artesan Pharma GmbH § Co. KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-537N/2020 | 2020-12-01 | VALIDE |
| 26 | Dologan Denk | Paracetamol Ibuprofène Cafféine | 250 mg 200 mg 50 mg | Comprimé pelliculé | B/20 | Génerique | Artesan Pharma GmbH § Co. KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-536N/2020 | 2020-12-01 | VALIDE |
| 27 | Doloforte Denk | Chlorhydrate de Tramadol Paracétamol | 37,5 mg 325 mg | Comprimé pelliculé | B/20 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-535N/2020 | 2020-12-01 | VALIDE |
| 28 | Deslora-Denk | Desloratadine | 5 mg | Comprimé pelliculé | B/10 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-534N/2020 | 2020-12-01 | VALIDE |
| 29 | Cipro-Denk | Ciprofloxacine chlorhydrate | 750 mg | Comprimé pelliculé | B/8 | Génerique | allphamed PHARBIL Arzneimitell GmbH | Germany | DENK PHARMA GmbH § Co.KG | Germany | MSPLS-DPML-533N/2020 | 2020-12-01 | VALIDE |
| 30 | Cipro-Denk 500 | Ciprofloxacine chlorhydrate | 500 mg | Comprimé pelliculé | B/10 | Génerique | allphamed PHARBIL Arzneimitell GmbH | Germany | DENK PHARMA GmbH § Co.KG | Mauritius | MSPLS-DPML-532N/2020 | 2020-12-01 | VALIDE |
| 31 | Asu-Denk fixed dose | ARTESUNATE SULFAMETHOXYPYRAZINE PYRIMETHAMINE | 200 mg 500 mg 25 mg | Comprimé | B/3 | Génerique | Artesan Pharma GmbH § Co. KG | India | DENK PHARMA GmbH § Co.KG | Mauritius | MSPLS-DPML-531N/2020 | 2020-12-01 | VALIDE |
| 32 | Tracedol | Chlorhydate de Tramadol Paracétamol | 37,50 mg 325 mg | Comprimé | B/16 | Générique | VOVANTIS LABORATORIES LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-530N/2020 | 2020-09-30 | VALIDE |
| 33 | Surdex | Paracétamol Chlorhydrate de Phénylephrine Maléa | 125 mg 1 mg 2,5 mg | Sirop | Flacon de 60 ml | Générique | DORTMUND LABORATORIES PVT LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-529N/2020 | 2020-09-30 | VALIDE |
| 34 | Surdex | Paracétamol Caféine Chlorhydrate de Phénylephri | 500 mg 30 mg 5 mg 2 mg | Comprimé | B/12 | Générique | BLISS GVS PHARMA LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-528N/2020 | 2020-09-30 | VALIDE |
| 35 | Sirofen | Ibuprofène | 200 mg/1ml | Suspension buvable | Flacon de 150 ml | Générique | DORTMUND LABORATORIES PVT LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-527N/2020 | 2020-09-30 | VALIDE |
| 36 | Rinogrip | Paracétamol Maléate de Chlorphéniramine Acide a | 500 mg 25mg 200 mg | Sachet sans sucre | B/10 | Générique | BLISS GVS PHARMA LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-526N/2020 | 2020-09-30 | VALIDE |
| 37 | Rinogrip | Paracétamol Maléate de Chlorphéniramine Acide a | 500 mg 25mg 200 mg | Sachet | B/10 | Générique | BLISS GVS PHARMA LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-525N/2020 | 2020-09-30 | VALIDE |
| 38 | Malavan | Artésunate | 120 mg | Poudre pour solution injectable | B/1 | Générique | INDASI LIFESCIENCE PVT LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-524N/2020 | 2020-09-30 | VALIDE |
| 39 | Malavan | Artésunate | 60 mg | Poudre pour solution injectable | B/1 | Générique | INDASI LIFESCIENCE PVT LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-523N/2020 | 2020-09-30 | VALIDE |
| 40 | Malavan | Artésunate | 50 mg | Suppositoire | B/2 | Générique | BLISS GVS PHARMA LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-522N/2020 | 2020-09-30 | VALIDE |
| 41 | Lufanter | ARTEMETHER AND LUMEFANTRINE | 80 mg 480 mg | Sachet | B/6 | Générique | BLISS GVS PHARMA LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-521N/2020 | 2020-09-30 | VALIDE |
| 42 | Gynospan | Phloroglucinol anhydre Triméthylphloroglucinol | 116,70 mg 80 mg | Suppositoire | B/10 | Générique | BLISS GVS PHARMA LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-520N/2020 | 2020-09-30 | VALIDE |
| 43 | Gynospan | Phloroglucinol anhydre Triméthylphloroglucinol | 40 mg 0,04 mg | Ampoule pour injection | B/6 | Générique | INDASI LIFESCIENCE PVT LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-519N/2020 | 2020-09-30 | VALIDE |
| 44 | Gynospan | Phloroglucinol anhydre Triméthylphloroglucinol | 62,233 mg 80 mg | Comprimé | B/30 | Générique | BLISS GVS PHARMA LTD | India | IMEX PHARMA | Mauritius | MSPLS-DPML-518N/2020 | 2020-09-30 | VALIDE |
| 45 | Fuclo | Flucloxacilline Sodique | 500 mg | Poudre pour préparation injectable | B/1 | Générique | INJECT CARE PARENTERALS Pvt.Ltd | India | IMEX PHARMA | Mauritius | MSPLS-DPML-517N/2020 | 2020-09-30 | VALIDE |
| 46 | Fuclo | Flucloxacilline Sodique | 500 mg | Gélules | B/24 | Générique | MEDOPHARM Private Limited | India | IMEX PHARMA | Mauritius | MSPLS-DPML-516N/2020 | 2020-09-30 | VALIDE |
| 47 | Fuclo | Flucloxacilline Sodique | 250 mg | Suspension buvable | Flacon de 100 ml | Générique | MEDOPHARM Private Limited | India | IMEX PHARMA | Mauritius | MSPLS-DPML-515N/2020 | 2020-09-30 | VALIDE |
| 48 | Fuclo | Flucloxacilline Sodique | 1 g | Poudre pour préparation injectable | B/1 | Générique | INJECT CARE PARENTERALS Pvt.Ltd | India | IMEX PHARMA | Mauritius | MSPLS-DPML-514N/2020 | 2020-09-30 | VALIDE |
| 49 | Dolimex migraine | Paracétamol Caféine | 500 mg 50 mg | Comprimé effervescent | B/16 | Générique | VOVANTIS LABORATORIES LTD. | France | IMEX PHARMA | Mauritius | MSPLS-DPML-513N/2020 | 2020-09-30 | VALIDE |
| 50 | Dolimex | Paracetamol | 10 mg/ml | Solution pour perfusion | Poche de 100 ml | Générique | MACO PHARMA | India | IMEX PHARMA | Mauritius | MSPLS-DPML-512N/2020 | 2020-09-30 | VALIDE |
| 51 | Dolimex | Paracétamol | 200 mg | Sachet | B/12 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-511N/2020 | 2020-09-30 | VALIDE |
| 52 | Dolimex | Paracétamol | 1000 mg | Sachet | B/8 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-510N/2020 | 2020-09-30 | VALIDE |
| 53 | Dolimex | Paracétamol | 500 mg | Sachet | B12 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-509N/2020 | 2020-09-30 | VALIDE |
| 54 | Dolimex | Paracétamol | 300 mg | Sachet | B/12 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-508N/2020 | 2020-09-30 | VALIDE |
| 55 | Dolimex | Paracétamol | 500 mg | Comprimé effervescent | B/16 | Générique | VOVANTIS LABORATORIES LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-507N/2020 | 2020-09-30 | VALIDE |
| 56 | Dolimex | Paracétamol | 1000 mg | Comprimé effervescent | B/8 | Générique | VOVANTIS LABORATORIES LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-506N/2020 | 2020-09-30 | VALIDE |
| 57 | Diaformine | Metformine | 500 mg | Comprimé | B/30 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-505N/2020 | 2020-09-30 | VALIDE |
| 58 | Diaformine | Métformine | 1000 mg | Comprimé LP | B/30 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-504N/2020 | 2020-09-30 | VALIDE |
| 59 | Diaformine | Métformine | 850 mg | Comprimé LP | B/30 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-503N/2020 | 2020-09-30 | VALIDE |
| 60 | Cofantrine | ARTEMETHER AND LUMEFANTRINE | 180 mg 1080 mg | Poudre pour suspension buvable | Flacon de 60 ml | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-502N/2020 | 2020-09-30 | VALIDE |
| 61 | Cofantrine | ARTEMETHER AND LUMEFANTRINE | 20 mg 120 mg | Comprimé dispersible | B/6 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-501N/2020 | 2020-09-30 | VALIDE |
| 62 | Cofantrine | ARTEMETHER AND LUMEFANTRINE | 80 mg 480 mg | Comprimé | B/6 | Générique | BLISS GVS PHARMA LTD. | India | IMEX PHARMA | Mauritius | MSPLS-DPML-500N/2020 | 2020-09-30 | VALIDE |
| 63 | Clavumoccid | Amoxicilline Acide Clavulanique | 1000 mg 125 mg | Comprimé | B/20 | Générique | MEDOPHARM Private Limited | India | IMEX PHARMA | Mauritius | MSPLS-DPML-499N/2020 | 2020-09-30 | VALIDE |
| 64 | Clavuject | Amoxicilline Acide Clavulanique | 1000 mg 200 mg soit 1,2 G | Poudre pour préparation injectable | B/1 | Générique | INJECT CARE PARENTERALS Pvt.Ltd | India | IMEX PHARMA | Kenya | MSPLS-DPML-497N/2020 | 2020-09-30 | VALIDE |
| 65 | Anomex | Acétate d'hydrocortisone Lidocaine Oxyde de Zinc | 0,25% 3,0 % 5,0 % 0,5 % | Suppositoire | B/10 | Générique | BLISS Gvs Pharma Ltd | Kenya | IMEX PHARMA | Kenya | MSPLS-DPML-497N/2020 | 2020-09-30 | VALIDE |
| 66 | Kenazole | Ketoconazole | 0.02 | Crème | Tube de 20g | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-496N/2020 | 2020-09-30 | VALIDE | |
| 67 | Ibupar | Ibuprofène Paracétamol | 400 mg 325 mg | Comprimé | B/1x10 | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-495N/2020 | 2020-09-30 | VALIDE | |
| 68 | Junior Zinc | Sulfate de Zinc Monohydrate | 20 mg | Comprimé | B/10x10 | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-494N/2020 | 2020-09-30 | VALIDE |
| 69 | Dacold | Paracétamol Chlorpheniramine maléate Pseudoephe | 120 mg + 2 mg + 10 mg/ 5 ml | Sirop | 100 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-493N/2020 | 2020-09-30 | VALIDE |
| 70 | Dacold | Paracétamol Chlorpheniramine maléate Pseudoephe | 400 mg 4 mg 30 mg 30 mg | Capsule | B/10x10 | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-492N/2020 | 2020-09-30 | VALIDE |
| 71 | Stopacid | Hydroxyde d'Aluminium Trisilicate de Magnésium | 120 mg + 250 mg/ 5ml | suspension buvable | 100 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-491N/2020 | 2020-09-30 | VALIDE |
| 72 | Stopacid | Hydroxyde d'Aluminium Trisilicate de Magnésium | 120 mg 250 mg | Comprimé | B/10X10 | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-490N/2020 | 2020-09-30 | VALIDE |
| 73 | Womnil | Albendazole | 200 mg/5ml | Suspension buvable | 10 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-489N/2020 | 2020-09-30 | VALIDE |
| 74 | Vermout | Mebendazole | 100 mg/5ml | Suspension buvable | 30 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-488N/2020 | 2020-09-30 | VALIDE |
| 75 | Minodine | Paromomycine | 250 mg | Comprimé | B/2x10 | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-487N/2020 | 2020-09-30 | VALIDE |
| 76 | Minodine | Paromomycine | 125 mg/5 ml | Sirop | 60 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-486N/2020 | 2020-09-30 | VALIDE |
| 77 | Ibupar | Ibuprofene Paracetamol | 100 mg + 120 mg / 5ml | Suspension buvable | 60 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-485N/2020 | 2020-09-30 | VALIDE |
| 78 | Eflaron Plus | Benzoate de Métronidazole Furoate de diloxamide | 200 mg 250 mg/5 ml | Suspension buvable | 100 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-484N/2020 | 2020-09-30 | VALIDE |
| 79 | Dawasolone | Prednisolone | 5 mg | Comprimé | B/10x10 | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-483N/2020 | 2020-09-30 | VALIDE |
| 80 | Dawamisole | Levamisole HCl | 40 mg/5ml | Sirop | 15 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-482N/2020 | 2020-09-30 | VALIDE |
| 81 | Dawa-Cpm | Chlorpheniramine maléate | 4 mg | Comprimé | B/10x10 | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-481N/2020 | 2020-09-30 | VALIDE |
| 82 | Dawa-Cpm | Chlorpheniramine maléate | 2 mg / 5ml | Sirop | 60 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-480N/2020 | 2020-09-30 | VALIDE |
| 83 | Dawaclox | Cloxacilline de Sodium | 125 mg/5 ml | Sirop | 100 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Kenya | MSPLS-DPML-479N/2020 | 2020-09-30 | VALIDE |
| 84 | Daprofen | Ibuprofene | 100 mg/5ml | Sirop | 100 ml | Générique | DAWA LIMITED | Kenya | DAWA LIMITED | Uganda | MSPLS-DPML-478N/2020 | 2020-09-30 | VALIDE |
| 85 | Dacof | Salbutamol sulfate Bromhexine Hydrochloride Guaife | 2,0 mg 4,0 mg 100,0 mg/5ml | Sirop | 100 ml | Générique | DAWA LIMITED | Uganda | DAWA LIMITED | Uganda | MSPLS-DPML-477N/2020 | 2020-09-30 | VALIDE |
| 86 | Zinkora | Glucose anhydre Chloride de Na Dihydrate Citrate T | 13.5 g 2.6 g 2.9 g 1.5 g 20 mg | Sachet + Comprimé | 20.5 g/sachet + B/10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-476N/2020 | 2020-06-19 | VALIDE |
| 87 | Iburen | Ibuprofene | B/10X10 | Comprimé | 200 mg | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-475N/2020 | 2020-06-19 | VALIDE |
| 88 | Erythroren | Erythromycine stearate | 125 mg/5 ml | Poudre pour suspsension orale | 100 ml | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-474N/2020 | 2020-06-19 | VALIDE |
| 89 | Cloxaren | Cloxacilline de Sodium | 125 mg/5 ml | poudre pour Suspension orale | 100 ml | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-473N/2020 | 2020-06-19 | VALIDE |
| 90 | Amoxiren DT 250 | Amoxicilline trihydrate | 250 mg | Comprimé dispersible | B/10x10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-472N/2020 | 2020-06-19 | VALIDE |
| 91 | Rezepine | Carbamazepine | 200 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-471N/2020 | 2020-06-19 | VALIDE |
| 92 | Renetrim-120 | Sulfamethoxazole Trimethoprime | 100 mmg 20 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-470N/2020 | 2020-06-19 | VALIDE |
| 93 | Mycoren | Nystatine | 500 000 UI | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-469N/2020 | 2020-06-19 | VALIDE |
| 94 | Mycoren-V | Nystatine | 100 000 UI | Comprimé vaginal | B/15 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-468N/2020 | 2020-06-19 | VALIDE |
| 95 | Metroren | Metronidazole Benzoate | 200 mg/5 ml | Suspension buvable | Fl/100 ml | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-467N/2020 | 2020-06-19 | VALIDE |
| 96 | Buscoren | Hyoscine butyl bromide | 10 mg | Comprimé | B/100 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-466N/2020 | 2020-06-19 | VALIDE |
| 97 | Aziren | Dihydrate d'Azithromycine | 500 mg | Comprimé | B/3 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-465N/2020 | 2020-06-19 | VALIDE |
| 98 | X-pel | Mebendazole | 100 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-464N/2020 | 2020-06-10 | VALIDE |
| 99 | ReZn | Sulfate de Zn monohydrate | 20 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-463N/2020 | 2020-06-10 | VALIDE |
| 100 | Revive | Glucose anhydre Chloride de Na Dihydrate Citrate T | 20.5 g/sachet | Sachet | 13.5 g 2.6 g 2.9 mg 1.5 g | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-462N/2020 | 2020-06-10 | VALIDE |
| 101 | Renetrim | Sulfamethoxazole Trimethoprime | 400 mg 80 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-461N/2020 | 2020-06-10 | VALIDE |
| 102 | Renechlor | Chloremphenicol | 250 mg | Capsule | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-460N/2020 | 2020-06-10 | VALIDE |
| 103 | Mycoren | Nystatine | 100 000 UI | Suspension buvable | Fl/30ml | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-459N/2020 | 2020-06-10 | VALIDE |
| 104 | Mint-O-Cool | Magnesium Trisilicate Hydroxyde d'Al | 250 mg 120 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-458N/2020 | 2020-06-10 | VALIDE |
| 105 | Loperaren | Loperamide Hydrochloride | 2 mg | Capsule | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-457N/2020 | 2020-06-10 | VALIDE |
| 106 | Ketoren | Ketoconazole | 200 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-456N/2020 | 2020-06-10 | VALIDE |
| 107 | Erythroren | Erythromycine stearate | 250 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-455N/2020 | 2020-06-10 | VALIDE |
| 108 | Chewcee | Acide Ascorbique | 100 mg | Comprimé | B/10X10 | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | Uganda | MSPLS-DPML-454N/2020 | 2020-06-10 | VALIDE |
| 109 | Benzyl Benzoate | Benzoate de Benzyle | 0.25 | Solution pour application cutanée | Fl/100 ml | Générique | Rene Industries Ltd | Uganda | Rene Industries Ltd | France | MSPLS-DPML-453N/2020 | 2020-06-10 | VALIDE |
| 110 | Amoxiren | Amoxicilline Trihydrate | 250 mg | Capsule | B/10X10 | Générique | Rene Industries Ltd | France | Rene Industries Ltd | Spain | MSPLS-DPML-452N/2020 | 2020-06-10 | VALIDE |
| 111 | Smectalia | Diosmectite | 3 G | Suspension buvable en sachet | B/12 | Princeps | BEAUFOUR IPSEN INDUSTRIE OU PHARMATIS | Germany | IPSEN PHARMA | Italy | MSPLS-DPML-450N/2020 | 2020-05-10 | VALIDE |
| 112 | ZALAIN ovule | Sertaconazole | 300 mg | Ovule | Boîte de 1 ovule | Générique | TROMMSDORFF GMBH & CO. KG | Italy | FERRER INTERNACIONAL, S.A. | Belgium | MSPLS-DPML-443N/2020 | 2020-05-11 | VALIDE |
| 113 | BERNY | Fosfomycine | 3 gr | Sachets | Flacon 3 g ml B/2 sachet | Princeps | So.se Pharma | India | So.se Pharma | Pakistan | MSPLS-DPML-319N/2019 | 2020-05-11 | VALIDE |
| 114 | FLUCAZOL | FLUCONAZOLE | 50mg/ 5ml | Poudre pour suspension buvable | Flacon 60 ml | Générique | Gracure Pharmaceuticals Limited | Pakistan | EXPHAR S.A | India | ABREMA147ND2024 | 2024-12-31 | VALIDE |
| 115 | DYSEN FORTE | Secnidazole | 1g | comprimé | B/2comprimés | Génerique | NABIQASIM INDUSTRIES LIMITED | India | NABIQASIM INDUSTRIES LIMITED | India | ABREMA146ND2024 | 2024-12-31 | VALIDE |
| 116 | VANCOSWISS 1 GM | Vancomycin Hydrochloride | 1g | Powder for Injection | Flacon de 20ml | Générique | Swiss Parenterals Ltd. | India | Swiss Parenterals Ltd | India | ABREMA145ND2024 | 2024-12-31 | VALIDE |
| 117 | SEVOSWISS | SEVOFLURANE USP | 250 mL | Liquid for Inhalation | Flacon de 250 ml | Générique | Swiss Parenterals Ltd. | India | Swiss Parenterals Ltd | India | ABREMA144ND2024 | 2024-12-31 | VALIDE |
| 118 | PHYILLINE | Aminophylline | 250mg/ml | SOLUTION FOR INJECTION | Flacon de 10 ml | Générique | Swiss Parenterals Ltd. | India | Swiss Parenterals Ltd | India | ABREMA143ND2024 | 2024-12-31 | VALIDE |
| 119 | ISOSWISS | ISOFLURANE USP | 250 ml | Liquid for Inhalation | Flacon de 250 ml | Générique | Swiss Parenterals Ltd. | India | Swiss Parenterals Ltd | Tunisia | ABREMA142ND2024 | 2024-12-31 | VALIDE |
| 120 | FUROSWISS | FUROSEMIDE | 10 MG/ML, 2 ML | SOLUTION FOR INJECTION | Flacon de 2ml | Générique | Swiss Parenterals Ltd. | Tunisia | Swiss Parenterals Ltd | Tunisia | ABREMA141ND2024 | 2024-12-31 | VALIDE |
| 121 | PAMISCAN | IOPAMIDOL | 370 mg/ml | Solution injectable | Flacon de 100 ml | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Kenya | ABREMA140ND2024 | 2024-12-31 | VALIDE |
| 122 | PAMISCAN | IOPAMIDOL | 370 mg/ml | Solution injectable | Flacon de 50 ml | Générique | LES LABORATOIRES MEDIS | Kenya | LES LABORATOIRES MEDIS | Kenya | ABREMA139ND2024 | 2024-12-31 | VALIDE |
| 123 | WIMAL | Sulfadoxine and Pyrimethamine | 500mg and 25mg | Comprimés | Boite de 300 cés | Génerique | Universal Corporation Limited | Kenya | Universal Corporation Limited | Kenya | ABREMA138ND2024 | 2024-12-31 | VALIDE |
| 124 | WIMAL | Sulfadoxine and Pyrimethamine | 250mg and 12.5mg | Comprimés | Boite de 300 cés | Génerique | Universal Corporation Limited | Kenya | Universal Corporation Limited | India | ABREMA137ND2024 | 2024-12-31 | VALIDE |
| 125 | RINACET | Cetirizine Hydrochloride | 5 mg | SYRUP | 60ml | Générique | DAWA LIMITED. | Uganda | DAWA LIMITED. | Uganda | ABREMA136ND2024 | 2024-12-31 | VALIDE |
| 126 | INDOREN | Indomethacine | 25mg | capsules | B/10x10 | Générique | RENE INDUSTRIES LTD | Uganda | RENE INDUSTRIES LTD | India | ABREMA135ND2024 | 2024-12-31 | VALIDE |
| 127 | MULTIREN | Multivitamines | 2500UI/300IU/1mg/500mcg/15mg/7.5mg | Comprimés pelliculés | B/10x10 | Génerique | RENE INDUSTRIES LTD | India | RENE INDUSTRIES LTD | India | ABREMA134ND2024 | 2024-12-31 | VALIDE |
| 128 | DIAZI | Diazepam | 10mg/2ml | SOLUTION FOR INJECTION | Flacon de 2ml | Générique | Swiss Parenterals Ltd. | India | Swiss Parenterals Ltd | Tunisia | ABREMA133ND2024 | 2024-12-31 | VALIDE |
| 129 | BUPI HEAVY | Bupivacaine Hydrochloride In Dextrose Injection | 5mg/ml | SOLUTION FOR INJECTION | Flacon de 4ml | Générique | Swiss Parenterals Ltd. | Tunisia | Swiss Parenterals Ltd | Tunisia | ABREMA132ND2024 | 2024-12-31 | VALIDE |
| 130 | IPNODIS MEDIS | Midazolam | 5 mg/ml | Solution injectable | B/10 Ampoules de 1 ml | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA131ND2024 | 2024-12-31 | VALIDE |
| 131 | PAMISCAN | IOPAMIDOL | 300 mg/ml | Solution injectable | Flacon de 100 ml | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Kenya | ABREMA130ND2024 | 2024-12-31 | VALIDE |
| 132 | PAMISCAN | IOPAMIDOL | 300 mg/ml | Solution injectable | Flacon de 50 ml | Générique | LES LABORATOIRES MEDIS | Kenya | LES LABORATOIRES MEDIS | Kenya | ABREMA129ND2024 | 2024-12-31 | VALIDE |
| 133 | ACEPAR | Paracetamol+Aceclofenac | 500mg +100mg | Comprimés | Boite de 10Cps | Générique | DAWA LIMITED. | Kenya | DAWA LIMITED. | Belgium | ABREMA128ND2024 | 2024-12-31 | VALIDE |
| 134 | CURAMOL | Paracetamol | 120mg | Suspension | Flacon de 100ml | Générique | DAWA LIMITED. | Belgium | DAWA LIMITED. | India | ABREMA127ND2024 | 2024-12-31 | VALIDE |
| 135 | Mosquirix) | Portion de la protéine circumsporozoîte de Plasm | 25 µg de RTS,S adjuvé avec ASO1E/0.5 ml dose | Pdre pr Injection | Flacon à 2Doses, (1dose=0.5ml). | Princeps | GlaxoSmithKline Biologicals.S.A | India | GlaxoSmithKline Biologicals.S.A | India | ABREMA126ND2024 | 2024-12-12 | VALIDE |
| 136 | TRIAFEN | Paracetamol, Ibuprofen, Cafeine | 325mg, 200mg, 30mg | Capsules | B/12x2 | Générique | Ratnatris Pharmaceutical Pvt Ltd | India | MEDEOR LIFE CARE LLP | India | ABREMA125ND2024 | 2024-10-31 | VALIDE |
| 137 | FLEXPAR | Methocarbamol, Paracetamol | 400mg, 500mg | Comprimé | B/12 | Générique | Ratnatris Pharmaceutical Pvt Ltd | India | MEDEOR LIFE CARE LLP | United States | ABREMA124ND2024 | 2024-10-31 | VALIDE |
| 138 | KALDOL | Paracetamol | 120mg/5ml | Suspension | Flacon de 100ml | Generique | LEBEN LABORATORIES PVT. LTD | China, People s Republic of | LEBEN LABORATORIES PVT. LTD | India | ABREMA123ND2024 | 2024-10-31 | VALIDE |
| 139 | CEFTRIAXONE | Ceftriaxone sodium | 1g | poudre pour injection | Flacon de 10ml | Générique | Reyoung Pharmaceutical Co., Ltd | India | M/s SHALINA HEALTHCARE DMCC | India | ABREMA121ND2024 | 2024-10-31 | VALIDE |
| 140 | CEFITAX 200 | Cefixime | 200mg | comprimé pelliculé | B/1 blister de 10 comprimés | Generique | VEGA BIOTEC PVT LTD | India | VEGA BIOTEC PVT LTD | United States | ABREMA120ND20204 | 2024-12-31 | VALIDE |
| 141 | ANTIGIT-DS | Aluminium,Magnesium+Simethicone | 400mg+400mg+50mg/5ml | Susp | Flacon de 170ml | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | Kenya | ABREMA119ND2024 | 2024-10-31 | VALIDE |
| 142 | CANDERM | Clotrimazole | 0.01 | Crème | tube/50g | Générique | GOPALDAS VISRAM &CO.LTD | Kenya | M/s SHALINA HEALTHCARE DMCC | Kenya | ABREMA118ND2024 | 2024-10-31 | VALIDE |
| 143 | Ampiclo-Dawa | Ampicilline trihydrate & Cloxacilline sodique | 125 mg & 125 mg | Poudre pour suspension buvable | Flacon de 100 ml | Générique | Dawa limited | Kenya | Dawa Limited | Sweden | ABREMA117ND2024 | 2024-10-31 | VALIDE |
| 144 | Ampiclo-Dawa 500 | Ampicilline trihydrate & Cloxacilline sodique | 250 mg & 250 mg | Capsule | B/10x10 | Générique | Dawa limited | Turkey | Dawa Limited | Sweden | ABREMA116ND2024 | 2024-10-31 | VALIDE |
| 145 | TERBINOL | CHLORHYDRATE DE TERIBINAFINE | 250MG | Comprimé | B/14 comprimé | Générique | NOBEL ILAC AS | Turkey | DAFRA PHARMA | Sweden | ABREMA115ND2024 | 2024-10-31 | VALIDE |
| 146 | DAFRAZOL | OMEPRAZOLE | 20MG | Gélule gastro-résistante | B/4x7 | Générique | NOBEL ILAC SANAYII VE TICONET A,S | Turkey | DAFRA PHARMA | United States | ABREMA114ND2024 | 2024-10-31 | VALIDE |
| 147 | DAFRAZOL | OMEPRAZOLE | 20MG | Gélule gastro-résistante | B/2x7 | Générique | NOBEL ILAC SANAYII VE TICONET A,S | India | DAFRA PHARMA | United Kingdom | ABREMA113ND2024 | 2024-10-31 | VALIDE |
| 148 | LOPRADE | Lopéramide | 2 mg | Comprimé | B/6x25 | Générique | SHALINA LABORATORIES PVT.LTD | India | M/s SHALINA HEALTHCARE DMCC | Egypt | ABREMA113ND2023 | 2023-12-29 | VALIDE |
| 149 | NARISOL Adulte | Xylomethazoline | 0.001 | Spray nasal | Flacon de 10 ml | Génerique | Westcoast Pharmaceutical Works Ltd | Egypt | BEKRA PHARMA UK LTD | Uganda | ABREMA112ND2024 | 2024-10-31 | VALIDE |
| 150 | TRILLERG OPHTALMIC | Antazoline hydrocoride, tetrizoline hydocloride | 0,5mg/ml,0,4mg/ml | Solution ophtalmique | Flacon de 10ml | Génerique | Orchidia Pharmaceutical Company | Uganda | Orchidia Pharmaceutical Company | United Kingdom | ABREMA112ND2024 | 2024-10-31 | VALIDE |
| 151 | NS BP | SODIUM CHLORIDE | 0,9% W/V | SOLUTION FOR INFUSION | Pochette de 100 ml | Générique | ABACUS PARENTERAL DRUGS | India | ABACUS PARENTERAL DRUGS LTD | Uganda | ABREMA112ND2023 | 2023-12-29 | VALIDE |
| 152 | NARISOL Pediatrique | Xylomethazoline | 0.0005 | Spray nasal | Flacon de 10 ml | Génerique | Westcoast Pharmaceutical Works Ltd | Uganda | BEKRA PHARMA UK LTD | United Kingdom | ABREMA111ND2024 | 2024-10-31 | VALIDE |
| 153 | XSONEN | NEAMYCIN SULPHATE ET DEXAMETHASONE SODIUM PHOSPHA | 0,3% W/V et 0,1% W/V | Collyre | Flacon 10 ml | Générique | ABACUS PARENTERAL DRUGS | India | ABACUS PARENTERAL DRUGS LTD | United States | ABREMA111ND2023 | 2023-12-29 | VALIDE |
| 154 | Bekracine®200 | Céfixime | 200 mg | Comprimé | B/10 | Générique | BAROQUE PHARMACEUTICALS PVT LTD | India | BEKRA PHARMA UK LTD | United Kingdom | ABREMA110ND2024 | 2024-10-31 | VALIDE |
| 155 | TINIZOL-500 | Tinidazole | 500 | Comprimé | B/4 | Générique | SHALINA LABORATORIES PVT.LTD | India | M/s SHALINA HEALTHCARE DMCC | United Kingdom | ABREMA110ND2023 | 2023-12-29 | VALIDE |
| 156 | Bekracine | Céfixime | 100 mg / 5 ml | Suspension buvable | Flacon de 60 ml | Générique | BAROQUE PHARMACEUTICALS PVT LTD | India | BEKRA PHARMA UK LTD | United Kingdom | ABREMA109ND2024 | 2024-10-31 | VALIDE |
| 157 | BEKRANEM | MEROPENEM | 1000 mg | Poudre pour injection ou perfusion | Ampoule de 10 ml | Générique | BRAWN LABORATORIES LIMITED | India | BEKRA PHARMA UK LTD | United Kingdom | ABREMA109ND2023 | 2023-12-29 | VALIDE |
| 158 | Azithromil®-500 | Azithromycine | 500 mg | Comprimé | B/3 | Générique | BAROQUE PHARMACEUTICALS PVT LTD | India | BEKRA PHARMA UK LTD | United Kingdom | ABREMA108ND2024 | 2024-10-31 | VALIDE |
| 159 | BEKRANEM | MEROPENEM | 500 mg | Poudre pour injection ou perfusion | Ampoule de 10 ml | Générique | BRAWN LABORATORIES LIMITED | India | BEKRA PHARMA UK LTD | Uganda | ABREMA108ND2023 | 2023-12-29 | VALIDE |
| 160 | CARDAL | Pantoprazole sodium+Domperidone | 40mg+30mg | Capsules | Boite de 30 Capsules | Génerique | BAROQUE PHARMACEUTICALS PVT LTD | Uganda | BEKRA PHARMA UK LTD | United Kingdom | ABREMA107ND2024 | 2024-10-31 | VALIDE |
| 161 | ABNAL | SODIUM CHLORIDE | 0.009 | Goutte nasale | Flacon 10 ml | Générique | ABACUS PARENTERAL DRUGS | India | ABACUS PARENTERAL DRUGS LTD | Uganda | ABREMA107ND2023 | 2023-12-29 | VALIDE |
| 162 | NEUROGIL-75 | Pregabaline | 75mg | Capsules | B/10x2 | Génerique | Westcoast Pharmaceutical Works Ltd | Uganda | BEKRA PHARMA UK LTD | United Kingdom | ABREMA106ND2024 | 2024-10-31 | VALIDE |
| 163 | ABPARA | PARACETAMOL | 1,0%W/V | SOLUTION FOR INFUSION | flacon de 100 ml | Générique | ABACUS PARENTERAL DRUGS | India | ABACUS PARENTERAL DRUGS LTD | Tunisia | ABREMA106ND2023 | 2023-12-29 | VALIDE |
| 164 | NEUROGIL-75 | Pregabaline | 75mg | Capsules | B/10x5 | Génerique | Westcoast Pharmaceutical Works Ltd | Tunisia | BEKRA PHARMA UK LTD | United Kingdom | ABREMA105ND2024 | 2024-10-31 | VALIDE |
| 165 | ESORAL 40 mg | Esoméprazole | 40 mg | Gélule gastro-résistante | B/4x7 | Générique | LES LABORATOIRES MEDIS | India | LES LABORATOIRES MEDIS | Tunisia | ABREMA105ND2023 | 2023-12-29 | VALIDE |
| 166 | AKEROL | Desloratadine | 5mg | Comprimés | Boite de 20Cp | Génerique | Westcoast Pharmaceutical Works Ltd | Tunisia | BEKRA PHARMA UK LTD | United Kingdom | ABREMA104ND2024 | 2024-10-31 | VALIDE |
| 167 | ESORAL 40 mg | Esoméprazole | 40 mg | Gélule gastro-résistante | B/2x8 | Générique | LES LABORATOIRES MEDIS | India | LES LABORATOIRES MEDIS | Tunisia | ABREMA104ND2023 | 2023-12-29 | VALIDE |
| 168 | AKEROL | Desloratadine | 2.5mg/5ml | sirop | Flacon de 60 ml | Génerique | Westcoast Pharmaceutical Works Ltd | Tunisia | BEKRA PHARMA UK LTD | India | ABREMA103ND2024 | 2024-10-31 | VALIDE |
| 169 | ESORAL 20 mg | Esoméprazole | 20 mg | Gélule gastro-résistante | B/4x7 | Générique | LES LABORATOIRES MEDIS | India | LES LABORATOIRES MEDIS | Tunisia | ABREMA103ND2023 | 2023-12-29 | VALIDE |
| 170 | SKDERM CREAM (Alu) | Bétamethasone Dipropionate Clotrimazole Gentamici | 0,05% w/w + 1,0% w/w +0,1% w/w | Crème | T/30 G | Générique | S Kant HEALTHCARE Ltd. | Tunisia | S Kant HEALTHCARE Ltd. | United States | ABREMA102ND2024 | 2024-12-31 | VALIDE |
| 171 | ESORAL 20 mg | Esoméprazole | 20 mg | Gélule gastro-résistante | B/2x8 | Générique | LES LABORATOIRES MEDIS | India | LES LABORATOIRES MEDIS | India | ABREMA102ND2023 | 2023-12-29 | VALIDE |
| 172 | BETASOL | Clobetasol Propionate | 0.0005 | Lotion | Flacon de 30 ml | Générique | SHALINA LABORATORIES PVT.LTD | India | M/s SHALINA HEALTHCARE DMCC | Belgium | ABREMA101ND2023 | 2023-12-29 | VALIDE |
| 173 | SKDERM CREAM (Lami) | Bétamethasone Dipropionate Clotrimazole Gentamici | 0,05% w/w + 1,0% w/w +0,1% w/w | Crème | T/30 G | Générique | S Kant HEALTHCARE Ltd. | India | S Kant HEALTHCARE Ltd. | India | ABREMA100ND2024 | 2024-12-31 | VALIDE |
| 174 | GENTASOL | SULFATE DE GENTAMYCINE | 0.003 | Collyre | Flacon 5 ml | Générique | Ahlcon Parenterals | India | EXPHAR S.A | France | ABREMA100ND2023 | 2023-12-29 | VALIDE |
| 175 | SKDERM CREAM (Lami | Bétamethasone Dipropionate Clotrimazole Gentamici | 0,05% w/w + 1,0% w/w +0,1% w/w | Crème | T/15 G | Générique | S Kant HEALTHCARE Ltd. | India | S Kant HEALTHCARE Ltd. | Egypt | ABREMA099ND2024 | 2024-12-31 | VALIDE |
| 176 | PEDIAVIT | MULTIVITAMINE | TBD | Sirop | flacon de 100 ml | Générique | TEJKAMAL PHARMACEUTICALS PVT LTD | Egypt | B&O PHARMA | India | ABREMA099ND2023 | 2023-12-29 | VALIDE |
| 177 | CONJYCLEAR | Olopatadine Hydrochloride | 1 mg/ml | Solution ophtalmique | Flacon de 5 ml | Générique | ORCHIDIA PHARMACEUTICAL Company | India | ORCHIDIA PHARMACEUTICAL INDUSTRIES | Egypt | ABREMA098ND2023 | 2023-12-29 | VALIDE |
| 178 | VEGACOL | Chloremphenicol | 0.5%w/v | collyre | Flacon de 10ml | Generique | VEGA BIOTEC PVT LTD | Egypt | VEGA BIOTEC PVT LTD | Saudi Arabia | ABREMA098ND20204 | 2024-12-31 | VALIDE |
| 179 | TWINZOL | Dorzolamide hydrochloride/Timolol | 20mg/6.86mg/ml | Solution ophtalmique | Fl/5ml | Générique | Orchidia pharmaceutical company | Saudi Arabia | Orchidia pharmaceutical company | United States | ABREMA097ND2024 | 2024-10-31 | VALIDE |
| 180 | DEXAFLOX | Ofloxacine/Déxamétasone | 3mg/ml+1mg/ml | collyre en suspension ophtalmique | Flacon de 5ml | Générique | JAMJOON PHARMACEUTICALS FACTORY | China, People s Republic of | JAMJOON PHARMACEUTICALS FACTORY | Saudi Arabia | ABREMA097ND2023 | 2023-12-29 | VALIDE |
| 181 | AMOXY CAPSULES 250 | Amoxicilline trihydrate | 250mg | capsule | B/10X10 | Générique | Reyoung Pharmaceutical Co., Ltd | Saudi Arabia | M/s SHALINA HEALTHCARE DMCC | India | ABREMA096ND2024 | 2024-10-31 | VALIDE |
| 182 | BRIMO | Brimonidine tartrate | 2mg/ml | collyre en solution ophtalmique | Flacon de 5ml | Générique | JAMJOON PHARMACEUTICALS FACTORY | India | JAMJOON PHARMACEUTICALS FACTORY | France | ABREMA096ND2023 | 2023-12-29 | VALIDE |
| 183 | PREDLEB 5DT | Prednisolone | 5mg | Comprimés | Boite de 100 | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | United Kingdom | ABREMA095ND2024 | 2024-10-31 | VALIDE |
| 184 | TRIALGIC | Ibuprofène-Paracétamol-caféine | 200mg, 325mg, 30mg | Gélule | Boîte / 24 | Générique | MEDREICH LIMITED | India | B&O PHARMA | France | ABREMA095ND2023 | 2023-12-29 | VALIDE |
| 185 | SEKALGIC | Ibuprofen+Paracetamol+Cafeine | 100mg/125mg/5ml | sirop | Flacon de 100 ml | Génerique | BAROQUE PHARMACEUTICALS PVT LTD | India | BEKRA PHARMA UK LTD | United Kingdom | ABREMA094ND2024 | 2024-10-31 | VALIDE |
| 186 | FERLIX | Citrate d'ammonium ferrique-Acide folique-Vitamine | 200mg-0,5mg-5µg | Solution | flacon 200ml | Générique | TEJKAMAL PHARMACEUTICALS PVT LTD | India | B&O PHARMA | United States | ABREMA094ND2023 | 2023-12-29 | VALIDE |
| 187 | SEKALGIC | Ibuprofen+Paracetamol+Cafeine | 400mg/500mg/30mg | Comprimés | Boite de 12cp | Génerique | BAROQUE PHARMACEUTICALS PVT LTD | India | BEKRA PHARMA UK LTD | India | ABREMA093ND2024 | 2024-10-31 | VALIDE |
| 188 | DIPROSON | Betamethasone Dipropionate | 0.05% w/v | lotion | Bottle/30ml | Générique | Shalina Laboratories Pvt. Ltd | India | M/s SHALINA HEALTHCARE DMCC | Kenya | ABREMA093ND2023 | 2023-09-11 | VALIDE |
| 189 | SOLOCEF-S 1.5 gm | Ceftriaxone + SULBACTAM | 1G + 500 mg | Poudre pour injection | Flacon de 15 ml | Générique | YELURI FORMULATION PVT LTD | Kenya | YELURI FORMULATION PVT LTD | India | ABREMA092ND2024 | 2024-10-31 | VALIDE |
| 190 | KEMOXYL+F | AMOXICILLIN+FLUCLOXACILLIN | 250MG+250MG | CAPSULE | B/20 | LABORATORY & ALLIED LTD | India | LABORATORY & ALLIED LTD | Kenya | ABREMA092ND2023 | 2023-09-11 | VALIDE | |
| 191 | CIPROLEB-500 | Ciprofloxacine | 500 mg | Comprimé | B/10x10 | Generique | LEBEN LABORATORIES PVT LTD | Kenya | LEBEN LABORATORIES PVT LTD | India | ABREMA091ND2024 | 2024-10-31 | VALIDE |
| 192 | HOMAGON | PARACETAMOL+CHLORPHENIRAMINE MALEATE+ PSEUDOEPHEDR | 120 MG+2MG+10MG | Sirop | Flacon de 100 ml | LABORATORY & ALLIED LTD | India | LABORATORY & ALLIED LTD | India | ABREMA091ND2023 | 2023-09-11 | VALIDE | |
| 193 | CEBAY-200 DT | Céfixime | 200 mg | Comprime dispersible | B/10x1X10 | Generique | LEBEN LABORATORIES PVT LTD | India | LEBEN LABORATORIES PVT LTD | India | ABREMA090ND2024 | 2024-10-31 | VALIDE |
| 194 | ADIFLAM-SR | Diclofenac | 100mg | Comprimés | Boite de 100Cps | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | Egypt | ABREMA089ND2024 | 2024-10-31 | VALIDE |
| 195 | ATOREM 20 | ATORVASTATINE | 20mg | Comprimé pelliculé | B/1x10 | Générique | MSN LABORATORIES PRIVATE LIMITED | Egypt | MSN LABORATORIES PRIVATE LIMITED | India | ABREMA089ND2023 | 2023-09-11 | VALIDE |
| 196 | Orchapred | Prednisolone acetate | 10mg/ml | suspension ophtalmique | Fl/10ml | Générique | Orchidia pharmaceutical company | India | Orchidia pharmaceutical company | Sweden | ABREMA088ND2024 | 2024-10-31 | VALIDE |
| 197 | TOLVAT 15 | TOLVAPTAN | 15 mg | Comprimé | 1x 4`s | Générique | MSN LABORATORIES PRIVATE LIMITED | Turkey | MSN LABORATORIES PRIVATE LIMITED | Spain | ABREMA088ND2023 | 2023-09-11 | VALIDE |
| 198 | MUSCUREL® | Thiocolchicoside | 8 mg | Capsule | B/10 | Générique | BILIM ?LAÇ. SAN. VE TIC. A.? | Spain | DAFRA PHARMA GmbH | India | ABREMA087ND2024 | 2024-10-31 | VALIDE |
| 199 | DISFOR | Methocarbamol | 500 mg | Comprimé | B/20 | Générique | FAES FARMA, S.A | India | FAES FARMA, S.A | India | ABREMA087ND2023 | 2023-09-11 | VALIDE |
| 200 | MOXILEB | Amoxicilin | 125mg/5ml | Susspension oral | Flacon de 100ml | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | India | ABREMA086ND2024 | 2024-10-31 | VALIDE |
| 201 | LOSA-H | Losartan Potassium &Hydrochlorothiazide | 50mg+12,5mg | Comprimé | B/30 | Générique | Lincoln Pharmaceuticals Limited | India | Lincoln Pharmaceuticals Limited | India | ABREMA086ND2023 | 2023-09-11 | VALIDE |
| 202 | MOXILEB | Amoxicilin | 500mg | Capsules | Boite de 100Capsules | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | India | ABREMA085ND2024 | 2024-10-31 | VALIDE |
| 203 | Losa-50 | Losartan potassium USP | 50mg | Comprimé | B/100 | Générique | Lincoln Pharmaceuticals Limited | India | Lincoln Pharmaceuticals Limited | India | ABREMA085ND2023 | 2023-09-11 | VALIDE |
| 204 | KELVIN | Paracetamol | 500mg | Comprimés | Boite de 100Cps | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | India | ABREMA084ND2024 | 2024-10-31 | VALIDE |
| 205 | ANTHEL | Albendazole | 400 mg | Comprimé | 1 Tablet is in Blister Pack. | Générique | Lincoln Pharmaceuticals Limited | India | Lincoln Pharmaceuticals Limited | India | ABREMA084ND2023 | 2023-09-11 | VALIDE |
| 206 | L-TRIM | Co-trimoxazole | 240 mg/5 ml | Suspension orale | Flacon de 100 ml | Generique | LEBEN LABORATORIES PVT LTD | India | LEBEN LABORATORIES PVT LTD | India | ABREMA083ND2024 | 2024-10-31 | VALIDE |
| 207 | ANTHEL | Albendazole | 200 mg/5 ml | Oral Suspension | 10 ml Pink | Générique | Lincoln Pharmaceuticals Limited | India | Lincoln Pharmaceuticals Limited | India | ABREMA083ND2023 | 2023-09-11 | VALIDE |
| 208 | IBUPLUS | Ibuprofen+Paracetamol | 100mg+125mg | Suspension | Flacon de 100ml | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | Kenya | ABREMA082ND2024 | 2024-10-31 | VALIDE |
| 209 | MALACURE | Sulfadoxine & Pyrimethamine | 500mg/25mg | Comprimé | B/1000 | Générique | S KANT HEALTHCARE LTD. | Kenya | S KANT HEALTHCARE LTD. | India | ABREMA082ND2023 | 2023-09-11 | VALIDE |
| 210 | Eflaron 250 | Métronidazole | 250 mg | Comprimé | B/1000 | Générique | DAWA LIMITED | India | DAWA LIMITED | Kenya | ABREMA081ND2024 | 2024-10-31 | VALIDE |
| 211 | MALACURE | Sulfadoxine & Pyrimethamine | 500mg/25mg | Comprimé | B/100 | Générique | S KANT HEALTHCARE LTD. | Kenya | S KANT HEALTHCARE LTD. | India | ABREMA081ND2023 | 2023-09-11 | VALIDE |
| 212 | Eflaron 125 | Métronidazole | 125 mg | Suspension buvable | Flacon de 100 ml | Générique | DAWA LIMITED | India | DAWA LIMITED | Sweden | ABREMA080ND2024 | 2024-10-31 | VALIDE |
| 213 | MALACURE | Sulfadoxine & Pyrimethamine | 500mg/25mg | Comprimé | B/3 | Générique | S KANT HEALTHCARE LTD. | Greece | S KANT HEALTHCARE LTD. | Egypt | ABREMA080ND2023 | 2023-09-11 | VALIDE |
| 214 | Dafrazol® IV | Omeprazole | 40 mg | Poudre et solvent pour solution injectable, | Flacon de 10 ML | Générique | Anfarm Hellas S.A. | Egypt | DAFRA PHARMA GmbH | Kenya | ABREMA079ND2024 | 2024-10-31 | VALIDE |
| 215 | CONJYCLEAR FORTE | Olopatadine hydrochloride | 2mg/ml | Solution ophtalmique | Fl/5ml | Générique | Orchidia pharmaceutical company | Kenya | Orchidia pharmaceutical company | Spain | ABREMA078ND2024 | 2024-10-31 | VALIDE |
| 216 | NYCOSTAT | Nystatine | 100MUI | suspension orale | Flacon de 30ml | Générique | COSMOS LIMITED | Spain | COSMOS LIMITED | Kenya | ABREMA078ND2023 | 2023-08-18 | VALIDE |
| 217 | BILAXTEN | Bilastine | 6mg/ml | Colyre en solution | Flacon de 5ml | Générique | FAMAR HEALTH CARE | Kenya | FAES FAMA S.S | Uganda | ABREMA077ND2024 | 2024-12-31 | VALIDE |
| 218 | PAINOTAB | PARACETAMOL/CAFFEINE | 650mg/30mg | comprimé | Boite/100comprimés | Générique | COSMOS LIMITED | Uganda | COSMOS LIMITED | Kenya | ABREMA077ND2023 | 2023-08-18 | VALIDE |
| 219 | Doulutegravir (as sodium), Lamivudine & Tenofovir Disoproxil Fumarate | Doulutegravir (as sodium), Lamivudine & Tenofovir | 50 mg + 300 mg + 300 mg | Comprimé | B/30 | Générique | Cipla Quality Chemical Industries Limited | Kenya | Cipla Quality Chemical Industries Limited | India | ABREMA076ND2024 | 2024-12-31 | VALIDE |
| 220 | VARINIL | Amlodipine Besylate | 10mg | comprimé | B/28 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA076ND2023 | 2023-08-18 | VALIDE |
| 221 | ALWO-400 | Albendazol | 400mg | Comprimés | Boite de 100Cps | Generique | LEBEN LABORATORIES PVT. LTD | Kenya | LEBEN LABORATORIES PVT. LTD | France | ABREMA075ND2024 | 2024-10-31 | VALIDE |
| 222 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 25mg | comprimé | Boite/100comprimés | Générique | COSMOS LIMITED | France | COSMOS LIMITED | United States | ABREMA075ND2023 | 2023-08-18 | VALIDE |
| 223 | Tanakan | Ginkgo biloba L. | 40 mg | Comprimé enrobé | B/90 | Princeps | BEAUFOUR IPSEN INDUSTRIE | India | IPSEN CONSUMER HEALTHCARE | Kenya | ABREMA075ND2022 | 2022-12-30 | VALIDE |
| 224 | WORMEX 500 | Mebendazole | 500mg | comprimé | Boite/50x1comprimé | Générique | Shalina Laboratories Pvt. Ltd | Kenya | M/s SHALINA HEALTHCARE DMCC | Kenya | ABREMA074ND2024 | 2024-10-31 | VALIDE |
| 225 | CARDINOL | Atenolol | 100mg | comprimé pelliculé | B/2x14 | Générique | COSMOS LIMITED | Kenya | COSMOS LIMITED | India | ABREMA074ND2023 | 2023-08-18 | VALIDE |
| 226 | CARDINOL | Atenolol | 50mg | comprimé pelliculé | B/2x14 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | India | ABREMA073ND2023 | 2023-08-18 | VALIDE |
| 227 | LAMPYKLOX | Ampicilline Trihidrate+Cloxaciline Sodium | 250mg+250mg | Capsules | Boite de 100Capsules | Generique | LEBEN LABORATORIES PVT. LTD | India | LEBEN LABORATORIES PVT. LTD | Kenya | ABREMA072ND2024 | 2024-10-31 | VALIDE |
| 228 | LEBASMA | Salbutamol | 2mg/5 ml | Solution buvable | Flacon de 100 ml | Generique | LEBEN LABORATORIES PVT LTD | Kenya | LEBEN LABORATORIES PVT LTD | India | ABREMA072ND2024 | 2024-10-31 | VALIDE |
| 229 | HARTEZE | RIVAROXABAN | 20mg | Comprimé pelliculé | B/28 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA072ND2023 | 2023-08-18 | VALIDE |
| 230 | AZILEB-500 | Azithromycine | 500 mg | Comprimé | B/3 | Generique | LEBEN LABORATORIES PVT LTD | Kenya | LEBEN LABORATORIES PVT LTD | India | ABREMA071ND2024 | 2024-10-31 | VALIDE |
| 231 | HARTEZE | RIVAROXABAN | 15mg | Comprimé pelliculé | B/28 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA071ND2023 | 2023-08-18 | VALIDE |
| 232 | AZILEB-200 | Azithromycine | 200 mg/5 ml | Suspension buvable | Flacon de 30 ml | Generique | LEBEN LABORATORIES PVT LTD | Kenya | LEBEN LABORATORIES PVT LTD | United Kingdom | ABREMA070ND2024 | 2024-10-31 | VALIDE |
| 233 | HARTEZE | RIVAROXABAN | 10mg | Comprimé pelliculé | B/28 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA070ND2023 | 2023-08-18 | VALIDE |
| 234 | Amatrix®1000 SR | Metformine | 1000 mg | Comprimé | B/30 | Générique | BAROQUE PHARMACEUTICALS PVT LTD | Kenya | BEKRA PHARMA UK LTD | United Kingdom | ABREMA069ND2024 | 2024-10-31 | VALIDE |
| 235 | Glucomet 850mg | Metformin Hydrochloride | 850mg | comprimé pelliculé | Boite/28,56,100comprimés pelliculé | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA069ND2023 | 2023-08-18 | VALIDE |
| 236 | PALUMIL® Adulte | Artéméther Luméfantrine | 80 mg 480 mg | Comprimé | B/6 | Générique | BAROQUE PHARMACEUTICALS PVT LTD | Kenya | BEKRA PHARMA UK LTD | India | ABREMA068ND2024 | 2024-10-31 | VALIDE |
| 237 | GLUCOMET 500 | Metformin Hydrochloride | 500mg | comprimé pelliculés | Boite/28 comprimés/Boite/56comprimés | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA068ND2023 | 2023-08-18 | VALIDE |
| 238 | HYBRO-10 | Hyoscine Buthyl Bromide | 10 mg | Comprimé | B/10x10 | Générique | M/S MEDOPHARM | Kenya | MEDOPHARM PRIVATE LIMITED | India | ABREMA067ND2024 | 2024-10-31 | VALIDE |
| 239 | FUROSEMIDE | Furosemide | 40mg | comprimé | B/10x10 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA067ND2023 | 2023-08-18 | VALIDE |
| 240 | EMCAR-200 | Carbamazepine | 200 mg | Comprimé | B/10x10 | Générique | M/S MEDOPHARM | Kenya | MEDOPHARM PRIVATE LIMITED | India | ABREMA066ND2024 | 2024-10-31 | VALIDE |
| 241 | PERGALIN | Pregabalin | 75mg | capsules | B/3x10 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA066ND2023 | 2023-09-12 | VALIDE |
| 242 | M-DOPA 250 | Methyldopa | 250 mg | Comprimé pelliculé | B/10x10 | Générique | M/S MEDOPHARM | Kenya | MEDOPHARM PRIVATE LIMITED | India | ABREMA065ND2024 | 2024-10-31 | VALIDE |
| 243 | ES-OMECOS 40 | ESOMEPRAZOLE | 40mg | Comprimé pelliculé | B/3x10 | Générique | COSMOS LIMITED | India | COSMOS LIMITED | Kenya | ABREMA065ND2023 | 2023-08-18 | VALIDE |
| 244 | DORFEN | Aceclofenac | 100 mg | Comprimé pelliculé | B/3x10 | Générique | TRIVENI FORMULATIONS LMITED | Kenya | TRIVENI FORMULATIONS LIMITED | India | ABREMA064ND2024 | 2024-10-31 | VALIDE |
| 245 | COSMOL | Paracetamol | 120mg/5ml | suspension buvable | Flacon de 100ml | Générique | COSMOS LIMITED | India | COSMOS LIMITED | India | ABREMA064ND2023 | 2023-08-18 | VALIDE |
| 246 | ELPENEM-100 | MEROPENEM | 1000 MG | Poudre pour injection | Flacon de 30 ml | Générique | YELURI FORMULATION PVT LTD | India | YELURI FORMULATION PVT LTD | India | ABREMA063ND2024 | 2024-10-31 | VALIDE |
| 247 | VIROPIL | Lamivudine/Tenofovir/Dolutegravir | 300mg/300mg/50mg | comprimé péllicullé | B/90 | Générique | EMCURE PHARMACEUTICALS LIMITED | India | EMCURE PHARMACEUTICALS LIMITED | India | ABREMA063ND2023 | 2023-08-18 | VALIDE |
| 248 | DOXYLEB | Doxycycline hyclate | 100 mg | Capsule | B/10x10 | Generique | LEBEN LABORATORIES PVT LTD | India | LEBEN LABORATORIES PVT LTD | United Kingdom | ABREMA062ND2024 | 2024-10-31 | VALIDE |
| 249 | VIROPIL | Lamivudine/Tenofovir/Dolutegravir | 300mg/300mg/50mg | comprimé péllicullé | B/30 | Générique | EMCURE PHARMACEUTICALS LIMITED | India | EMCURE PHARMACEUTICALS LIMITED | Sweden | ABREMA062ND2023 | 2023-08-18 | VALIDE |
| 250 | CARDIOTEM | Amlodipine | 10mg | Comprimés | Boite de 30 Cp | Génerique | BAROQUE PHARMACEUTICALS PVT LTD | Greece | BEKRA PHARMA UK LTD | India | ABREMA061ND2024 | 2024-10-31 | VALIDE |
| 251 | MERONIA 500 IV | MEROPENEM | 500MG | Injectable | Poudre pour 20 ml de solution | Générique | ANFARM HELLAS S.A | India | DAFRA PHARMA | United Kingdom | ABREMA061ND2023 | 2023-08-18 | VALIDE |
| 252 | BACTOXIME DT 200 | Céfixime | 200 mg | Comprimé dispersible | B/1x10 | Générique | M/S ASSOCIATED BIOTECH | India | RENA EXPORTS PVT LTD | Sweden | ABREMA061ND2022 | 2022-12-30 | VALIDE |
| 253 | CARDIOTEM | Amlodipine | 5mg | Comprimés | Boite de 30 Cp | Génerique | BAROQUE PHARMACEUTICALS PVT LTD | Greece | BEKRA PHARMA UK LTD | India | ABREMA060ND2024 | 2024-10-31 | VALIDE |
| 254 | MERONIA 1000 IV | MEROPENEM | 1000MG | Injectable | Poudre pour 30 ml de solution | Générique | ANFARM HELLAS S.A | India | DAFRA PHARMA | India | ABREMA060ND2023 | 2023-08-18 | VALIDE |
| 255 | BACTOXIME DS 100 | Céfixime | 100 mg | Suspension orale | Flacon de 60 ml | Générique | M/S ASSOCIATED BIOTECH | India | RENA EXPORTS PVT LTD | Sweden | ABREMA060ND2022 | 2022-12-30 | VALIDE |
| 256 | TRITINI | Tinidazole | 500 mg | Comprimé | B/25x4 | Générique | TRIVENI FORMULATIONS LMITED | Turkey | TRIVENI FORMULATIONS LIMITED | Egypt | ABREMA059ND2024 | 2024-10-31 | VALIDE |
| 257 | SEKROL | CHLORHYDRATE D'AMBROXOL | 15MG/5ML | Sirop | Flacon de 100 ml | BILIM ILAC SANAYII VE TICARET AS | Egypt | DAFRA PHARMA | India | ABREMA059ND2023 | 2023-08-18 | VALIDE | |
| 258 | MOBITIL | Meloxicam | 15 mg | Comprimé pelliculé | B/10 | Générique | MEDICAL UNION PHARMACEUTICALS (MUP) | India | MEDICAL UNION PHARMACEUTICALS (MUP) | Sweden | ABREMA058ND2024 | 2024-06-28 | VALIDE |
| 259 | PIROXICAM | Piroxicam | 20 mg | Capsule | B/10x10 | Générique | TRIVENI FORMULATIONS LMITED | Turkey | TRIVENI FORMULATIONS LIMITED | Belgium | ABREMA058ND2024 | 2024-10-31 | VALIDE |
| 260 | SEKROL | CHLORHYDRATE D'AMBROXOL | 30MG/5ML | Sirop | Flacon de 150ml | BILIM ILAC SANAYII VE TICARET AS | India | DAFRA PHARMA | Sweden | ABREMA058ND2023 | 2023-08-18 | VALIDE | |
| 261 | FLOXSOL | NORFLOXACINE | 0.003 | Collyre | Flacon 5 ml | Générique | Ahlcon Parenterals | Turkey | EXPHAR S.A | Sweden | ABREMA057ND2024 | 2024-06-28 | VALIDE |
| 262 | Amifer® Junior | (Iron (III) hydroxide polymaltose complex (IPC) | 50 mg/ 5 ml | Sirop | Flacon de 150 ml | Générique | SANTA FARMA ?laç Sanayii A.?. | Turkey | DAFRA PHARMA GmbH | United States | ABREMA057ND2024 | 2024-10-31 | VALIDE |
| 263 | PAROL | Paracétamol | 500MG | Comprimé | B/30 comprimé | Générique | ATABAY ILAC FABRIKASI | India | DAFRA PHARMA | Sweden | ABREMA057ND2023 | 2023-08-18 | VALIDE |
| 264 | ERYSHAL 250 | Erythromycine stearate | 250mg | Comprimé pelliculé | Blister/10 comprimés pelliculés | Générique | Shalina Laboratories Pvt. Ltd | Turkey | M/s SHALINA HEALTHCARE DMCC | France | ABREMA056ND2024 | 2024-06-28 | VALIDE |
| 265 | PAROL | Paracétamol | 250MG/5ML | Sirop | Flacon de 100 ml | Générique | ATABAY ILAC FABRIKASI | France | DAFRA PHARMA | United States | ABREMA056ND2023 | 2023-08-18 | VALIDE |
| 266 | TANAKAN | Extrait de Ginkgo biloba | 40 mg/ml | Solution buvable | Flacon de 30 ml | Princeps | BEAUFOUR IPSEN INDUSTRIE | India | IPSEN CONSUMER HEALTHCARE | Sweden | ABREMA056ND2022 | 2022-12-30 | VALIDE |
| 267 | GLIBEN M | Glibenclamide/Metformine Hydrochloride | 5mg/500mg | comprimé | B/30 | Générique | Shalina Laboratories Pvt. Ltd | Turkey | M/s SHALINA HEALTHCARE DMCC | Tunisia | ABREMA055ND2024 | 2024-06-28 | VALIDE |
| 268 | PEDIFEN | IBUPROFENE | 100MG/5ML | Sirop | Flacon de 100 ml | Générique | ATABAY ILAC FABRIKASI | Tunisia | DAFRA PHARMA | United States | ABREMA055ND2023 | 2023-08-18 | VALIDE |
| 269 | NORMOPTIC 0,5% | Timolol Maleate | 0.683g | Collyre | Flacon de 5ml | Générique | LES LABORATOIRES MEDIS | India | LES LABORATOIRES MEDIS | Sweden | ABREMA055ND2022 | 2022-12-30 | VALIDE |
| 270 | IBUCAP COLD FLU | Chlorpheniramine Maleate/Paracetamol/Phenylephrine | 2mg/500mg/5mg/30mg | comprimé | Boite/4comprimés | Générique | Shalina Laboratories Pvt. Ltd | Turkey | M/s SHALINA HEALTHCARE DMCC | Spain | ABREMA054ND2024 | 2024-06-28 | VALIDE |
| 271 | TERBINOL | CHLORHYDRATE DE TERBINAFINE | 10 mg/g | Crème | Tude de 15 gr | NOBEL ILAC AS | Spain | DAFRA PHARMA | India | ABREMA054ND2023 | 2023-08-18 | VALIDE | |
| 272 | Nasoaldo | Mometasone | 50 microgrammes | Suspension pour pulvérisation nasale | Tube de 140 doses | Générique | Laboratorio Aldo-Union, S.L | India | Laboratoire Aldo-Union,SL | Kenya | ABREMA054ND2022 | 2022-12-30 | VALIDE |
| 273 | CIPROFLOXACIN | Ciprofloxacine | 500 mg | Comprimé | B/10x10 | Générique | MEDOPHARM PRIVATE LIMITED | Finland | MEDOPHARM PRIVATE LIMITED | Tunisia | ABREMA053ND2024 | 2024-06-28 | VALIDE |
| 274 | MIRENA | Levonorgestrel | 52 mg | DIU | B/1 | Princeps | BAYER OY | Tunisia | BAYER EAST AFRICA LIMITED | United States | ABREMA053ND2023 | 2023-09-11 | VALIDE |
| 275 | FENTANYL Médis | Fentanyl citrate | 0,5 mg/10 ml | Solution injectable | Ampoule de 10 ml, B/10 | Générique | LES LABORATOIRES MEDIS | India | LES LABORATOIRES MEDIS | Tunisia | ABREMA053ND2022 | 2022-12-30 | VALIDE |
| 276 | SULFATRIM FORTE | Sulfamethoxazole Trimethoprime | 800 mg 160 mg | Comprimé | B/10 | Générique | MCCOPY PHARMA PVT LTD | Tunisia | M/s SHALINA HEALTHCARE DMCC | Morocco | ABREMA052ND2023 | 2023-08-18 | VALIDE |
| 277 | FENTANYL Médis | Fentanyl citrate | 0,1mg/2ml | Solution injectable | Ampoule de 2 ml, B/10 | Générique | LES LABORATOIRES MEDIS | Morocco | LES LABORATOIRES MEDIS | United States | ABREMA052ND2022 | 2022-12-30 | VALIDE |
| 278 | ALGOFEN | Ibuprofene | 20mg/ml | suspension buvable en flacon | Flacon de 150ml | Générique | LABORATOIRES PHARMA 5 | India | LABORATOIRES PHARMA 5 | India | ABREMA051ND2024 | 2024-06-28 | VALIDE |
| 279 | SULFATRIM | Sulfamethoxazole Trimethoprime | 400 mg 80 mg | Comprimé | B/25x4 | Générique | ASTAMED HEALTHCARE PVT LTD | India | M/s SHALINA HEALTHCARE DMCC | United States | ABREMA051ND2023 | 2023-08-18 | VALIDE |
| 280 | ZINNIA P | Levonorgestrel Ethinylestradiol | 150 mcg/30 mcg | Comprimé | Bx28x3 | Générique | Mylan Laboratories Limited | India | Mylan Laboratories Limited | France | ABREMA051ND2022 | 2022-12-30 | VALIDE |
| 281 | RUFENAC 50 | Diclofenac sodique | 50 mg | Comprimé | B/10 | Générique | SHALINA LABORATORIES PVT.LTD | France | M/s SHALINA HEALTHCARE DMCC | Tunisia | ABREMA050ND2023 | 2023-08-18 | VALIDE |
| 282 | PHYSIODOSE | Chlorure de Sodium | 0.009 | Solution hygienique | Flacon de 5 ml, B/30 | Générique | LABORATOIRES GILBERT | Tunisia | LABORATOIRES GILBERT | United States | ABREMA050ND2022 | 2022-12-30 | VALIDE |
| 283 | CISATREX | Besilate de Cisatracurium | 2 mg/ml | Solution injectable | B/5 ampoules de 5 ml | Générique | LES LABORATOIRES MEDIS | India | LES LABORATOIRES MEDIS | France | ABREMA049ND2024 | 2024-06-28 | VALIDE |
| 284 | KIFARU-50 | Sildénafil Citrate | 50 mg | Comprimé | B/2 | Générique | SHALINA LABORATORIES PVT.LTD | France | M/s SHALINA HEALTHCARE DMCC | United States | ABREMA049ND2023 | 2023-08-18 | VALIDE |
| 285 | PHYSIODOSE | Chlorure de Sodium | 0.009 | Solution hygienique | Flacon de 5 ml, B/15 | Générique | LABORATOIRES GILBERT | India | LABORATOIRES GILBERT | Korea, Republic of (South Korea) | ABREMA049ND2022 | 2022-12-30 | VALIDE |
| 286 | KETAZOL | Ketoconazole | 0.02 | Crème | Tube de 15G | Générique | GOPALDAS VISRAM &CO.LTD | Korea, Republic of (South Korea) | M/s SHALINA HEALTHCARE DMCC | United States | ABREMA048ND2023 | 2023-08-18 | VALIDE |
| 287 | Dolutegravir, Lamivudine and Tenofovir Disoproxil fumarate 50 mg/ 300 mg /300 mg | Dolutegravir sodique + Lamivudine + Tenofovir dis | 50 mg 300 mg 300 mg | Comprimé pelliculé | B/90 | Générique | Aizant Drug Research Solutions Pvt.Ltd (Site I) et | India | CELLTRION, INC. | Korea, Republic of (South Korea) | ABREMA048ND2022 | 2022-12-30 | VALIDE |
| 288 | IBUCAP Forte | Ibuprofene Paracetamol Caffeine | 400 mg 325 mg 30 mg | Capsule | B/10x10 | Générique | SHALINA LABORATORIES PVT.LTD | Korea, Republic of (South Korea) | M/s SHALINA HEALTHCARE DMCC | India | ABREMA047ND2023 | 2023-08-18 | VALIDE |
| 289 | Dolutegravir, Lamivudine and Tenofovir Disoproxil fumarate 50 mg/ 300 mg /300 mg | Dolutegravir sodique + Lamivudine + Tenofovir dis | 50 mg 300 mg 300 mg | Comprimé pelliculé | B/30 | Générique | Aizant Drug Research Solutions Pvt.Ltd (Site I) et | India | CELLTRION, INC. | United States | ABREMA047ND2022 | 2022-12-30 | VALIDE |
| 290 | DOLUTEGRAVIR | Dolutegravir sodium | 50mg | Comprimé péllicullé | B/30 | Générique | MACLEODS PHARMACEUTICAL LTD | India | MACLEODS PHARMACEUTICAL LTD | India | ABREMA046ND2024 | 2024-06-28 | VALIDE |
| 291 | IBUCAP | Ibuprofene Paracetamol Caffeine | 200 mg 325 mg 30 mg | Capsule | B/10x10 | Générique | SHALINA LABORATORIES PVT.LTD | India | M/s SHALINA HEALTHCARE DMCC | ABREMA046ND2023 | 2023-08-18 | VALIDE | |
| 292 | Carbetocin Ferring | Carbétocine | 100 ?g/mL | Solution injectable | B/10x1 | Princeps | Ferring International Center S A | Sweden | Ferring Pharmaceuticals(China) Co., Ltd ou Steril- | China, People s Republic of | ABREMA046ND2022 | 2022-12-30 | VALIDE |
| 293 | Azimyn | Azithromycine dihydrate | 500 mg | Comprimé | B/3 | Générique | SHALINA LABORATORIES PVT.LTD | India | M/s SHALINA HEALTHCARE DMCC | United States | ABREMA045ND2023 | 2023-08-18 | VALIDE |
| 294 | ARTESUN | Artésunate | 120 mg | Poudre pour Solution injectable | B/1 + 1 ampoule de bicarbonate de sodium + 1 ampou | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA045ND2022 | 2022-12-31 | VALIDE |
| 295 | ENOXA 8000UI | ENOXAPARINE SODIQUE | 8000UI/0.8ml | solution injectable | boîte de 2 seringues pré-remplies | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA044ND2023 | 2023-08-18 | VALIDE |
| 296 | ARTESUN | Artésunate | 60 mg | Poudre pour Solution injectable | B/1 + 1 ampoule de bicarbonate de sodium + 1 ampou | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA044ND2022 | 2022-12-31 | VALIDE |
| 297 | ENOXA 6000UI | ENOXAPARINE SODIQUE | 6000UI/0.6ml | solution injectable | Boîte de 2 seringues pré-remplies | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA043ND2023 | 2023-08-18 | VALIDE |
| 298 | ARTESUN | Artésunate | 30 mg | Poudre pour Solution injectable | B/1 + 1 ampoule de bicarbonate de sodium + 1 ampou | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA043ND2022 | 2022-12-31 | VALIDE |
| 299 | ENOXA 4000UI | ENOXAPARINE SODIQUE | 4000UI/0.4ml | solution injectable | Boîte de 2 seringues pré-remplies | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA042ND2023 | 2023-08-18 | VALIDE |
| 300 | ARGESUN | Artésunate | 60 mg | Injectable | Ampoule de 3 ml | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA042ND2022 | 2022-12-30 | VALIDE |
| 301 | ENOXA 2000UI | ENOXAPARINE SODIQUE | 2000UI/0.2ml | Solution injectable | Boîte de 2 seringues pré-remplies | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA041ND2023 | 2023-08-18 | VALIDE |
| 302 | BETALEN | Bétamethasone phosphate sodique | 0,5 mg/ml | Solution buvable | Flacon de 30 ml | Générique | GRACURE PHARMACEUTICALS LIMITED | India | EXPHAR S.A | Belgium | ABREMA041ND2022 | 2022-12-30 | VALIDE |
| 303 | BETASOL | Clobetasol Propionate | 0.0005 | Crème | Tube de 15 G | Générique | SHALINA LABORATORIES PVT.LTD | India | M/s SHALINA HEALTHCARE DMCC | United States | ABREMA040ND2024 | 2024-06-28 | VALIDE |
| 304 | EPOMAX | ERYTHROPOIETINE | 2000 UI | Solution injectable | Flacon de 1 ml, B/10 | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA040ND2023 | 2023-05-15 | VALIDE |
| 305 | BETALEN | Bétamethasone phosphate sodique | 2 mg | Comprimé sécable | B/20 comprimés | Générique | GRACURE PHARMACEUTICALS LIMITED | India | EXPHAR S.A | Belgium | ABREMA040ND2022 | 2022-12-30 | VALIDE |
| 306 | DOLUTEGRAVIR | Dolutegravir | 10 mg | Comprimé dispersible | B/90 | Générique | Macleods Pharmaceuticals Ltd | India | MACLEODS PHARMACEUTICAL LTD | India | ABREMA039ND2024 | 2024-06-28 | VALIDE |
| 307 | Fluditec enfant 2% | carbocistéine | 2% (2g/100ml) | Sirop | flacon de 125ml | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA039ND2023 | 2023-03-26 | VALIDE |
| 308 | DICYNONE | Etamsylate | 500mg | Gélule | B/20 | Princeps | OM PHARMA SA | Sweden | OM PHARMA SA | Sweden | ABREMA039ND2022 | 2022-12-30 | VALIDE |
| 309 | CLEDOMOX 625 | Amoxicilline trihydrate & Acide clavulanique de K | 500 mg &125 mg | Comprimé | B/2x7 | Générique | MEDOPHARM PRIVATE LIMITED | India | MEDOPHARM PRIVATE LIMITED | India | ABREMA038ND2024 | 2024-06-28 | VALIDE |
| 310 | Fluditec 7.5% adultes sans sucre | carbocistéine | 7,5%(750mg/10ml | Solution buvable en sachet de 10 ml | 15sachets de 10ml | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA038ND2023 | 2023-03-26 | VALIDE |
| 311 | DICYNONE | étamsylate | 250mg/2ml | Injectable | Flacon 4x2ml | Princeps | OM PHARMA SA | Sweden | OM PHARMA SA | Sweden | ABREMA038ND2022 | 2022-12-30 | VALIDE |
| 312 | PREDILONE | Prednisolone | 5 mg | Comprimé | B/10x10 | Générique | REGAL PHARMACEUTICALS LTD | Kenya | REGAL PHARMACEUTICALS LTD | Kenya | ABREMA037ND2024 | 2024-06-28 | VALIDE |
| 313 | Fluditec 5% adultes Expectorant | carbocistéine | 5% (5g/100ml) | Sirop | flacon de 125ml | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA037ND2023 | 2023-03-26 | VALIDE |
| 314 | VILDA DENK 50 mg | Vildagliptine | 50 mg | Comprimé | B/28 | Génerique | COMBINO PHARM (Malta) LTD. | Malta | DENK PHARMA GmbH & Co. KG | Germany | ABREMA037ND2022 | 2022-12-30 | VALIDE |
| 315 | R21 malaria vaccine | R21 malaria antigen (Bulk) | 1 dose | Solution injectable | Flacon de 0.5 ML | Princeps | Serum Institute of India Pvt Ltd | India | SERUM INSTITUTE OF INDIA PVT. LTD | India | ABREMA036ND2024 | 2024-06-28 | VALIDE |
| 316 | TOT'HEMA | Fer, manganèse et cuivre | 50mg, 1,33 mg,0,7 mg | solution buvable en ampoule | B/20ampoule de 10ml | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA036ND2023 | 2023-03-26 | VALIDE |
| 317 | TORAS-DENK 5 | Torasemide | 5 mg | Comprimé | B/30 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA036ND2022 | 2022-12-30 | VALIDE |
| 318 | FUSIBACT | Acide fusidique | 20mg/g | pommade | tube de 15g | Générique | JAMJOON PHARMACEUTICALS FACTORY | Saudi Arabia | JAMJOON PHARMACEUTICALS FACTORY | Saudi Arabia | ABREMA035ND2024 | 2024-03-06 | VALIDE |
| 319 | IDEOS | Calcium Cholecalciferol | 500mg 400UI | comprimé à croquer | 15 comprimés, B/2 tubes | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA035ND2023 | 2023-03-26 | VALIDE |
| 320 | LEVO-DENK 500 | Levofloxacine | 500 mg | Comprimé pelliculé | B/10 | Génerique | ROTTENDORF PHARMA GmbH | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA035ND2022 | 2022-12-30 | VALIDE |
| 321 | WORMEX 100 | Mebendazole | 100mg | comprimés | Boite/25x6 comprimés | Générique | Shalina Laboratories Pvt. Ltd | India | M/s SHALINA HEALTHCARE DMCC | United States | ABREMA034ND2024 | 2024-03-06 | VALIDE |
| 322 | HELMINTOX | Embonate de pyrantel | 125ml/2,5ml | Suspension buvable | Flacon/15ml | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA034ND2023 | 2023-03-26 | VALIDE |
| 323 | LEVO-DENK 250 | Levofloxacine | 250 mg | Comprimé pelliculé | B/10 | Génerique | ROTTENDORF PHARMA GmbH | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA034ND2022 | 2022-12-30 | VALIDE |
| 324 | MEDOMOX 250 DT | Amoxicillin trihydrate | 250 mg | Comprimé | B/100 | Générique | MEDOPHARM PRIVATE LIMITED | India | MEDOPHARM PRIVATE LIMITED | India | ABREMA033ND2024 | 2024-03-06 | VALIDE |
| 325 | HELMINTOX | Embonate de pyrantel | 250mg | Comprimé pelliculé sécable | B/3 | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA033ND2023 | 2023-03-26 | VALIDE |
| 326 | GLIMEPIRIDE DENK 3 | Glimépiride | 3 mg | Comprimé | B/30 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA033ND2022 | 2022-12-30 | VALIDE |
| 327 | XOLA | Dorzolamide | 20mg/ml | collyre en solution ophtalmique | Flacon de 5ml | Générique | JAMJOON PHARMACEUTICALS FACTORY | Saudi Arabia | JAMJOON PHARMACEUTICALS FACTORY | Saudi Arabia | ABREMA032ND2024 | 2024-03-06 | VALIDE |
| 328 | VENOSMIL | Hidrosmine | 0.002 | Gel | Tube 60 G | Générique | FAES FARMA, S.A | Spain | FAES FARMA, S.A | Spain | ABREMA032ND2023 | 2023-03-16 | VALIDE |
| 329 | GLIMEPIRIDE DENK 2 | Glimépiride | 2 mg | Comprimé | B/30 | Génerique | DENK PHARMA GmbH § Co.KG | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA032ND2022 | 2022-12-30 | VALIDE |
| 330 | LUMITER DT | Artemether & Lumefantrine | 20mg/120mg | Comprimé dispersible | B/12 x30 | Générique | OXALIS LABS | India | Macleods Pharmaceuticals Limited | India | ABREMA031ND2024 | 2024-03-06 | VALIDE |
| 331 | Varosun | Rivaroxaban | 20 mg | Comprimés pelliculés | B/14 | Générique | Suzhou Erye Pharmaceutical Co., Ltd | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA031ND2023 | 2023-03-16 | VALIDE |
| 332 | DOLO-DENK GEL | Etofénamate | 100 mg/g | gel | T/50 G | Génerique | C.P.M. CONTRACTPHARMA GmbH | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA031ND2022 | 2022-12-30 | VALIDE |
| 333 | LUMITER DT | Artemether & Lumefantrine | 20mg/120mg | Comprimé dispersible | B/12 x1 | Générique | OXALIS LABS | India | Macleods Pharmaceuticals Limited | India | ABREMA030ND2024 | 2024-03-06 | VALIDE |
| 334 | Varosun | Rivaroxaban | 10 mg | Comprimés pelliculés | B/10 | Générique | Suzhou Erye Pharmaceutical Co., Ltd | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA030ND2023 | 2023-03-16 | VALIDE |
| 335 | DOLO-DENK GEL | Etofénamate | 100 mg/g | gel | T/20 G | Génerique | C.P.M. CONTRACTPHARMA GmbH | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA030ND2022 | 2022-12-30 | VALIDE |
| 336 | LUMITER DT | Artemether & Lumefantrine | 20mg/120mg | Comprimé dispersible | B/6 x30 | Générique | OXALIS LABS | India | Macleods Pharmaceuticals Limited | India | ABREMA029ND2024 | 2024-03-06 | VALIDE |
| 337 | Tanakan | Ginkgo biloba L | 40 mg | Comprimé enrobé | B/30 | Princeps | BEAUFOUR IPSEN INDUSTRIE | France | IPSEN CONSUMER HEALTHCARE | France | ABREMA029ND2023 | 2023-03-16 | VALIDE |
| 338 | CLOTRI-DENK 1% CREAM | Clotrimazole | 0.01 | Crème | T/20 G | Génerique | C.P.M. CONTRACTPHARMA GmbH | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA029ND2022 | 2022-12-30 | VALIDE |
| 339 | LUMITER DT | Artemether & Lumefantrine | 20mg/120mg | Comprimé dispersible | B/6x1 | Générique | OXALIS LABS | India | Macleods Pharmaceuticals Limited | India | ABREMA028ND2024 | 2024-03-06 | VALIDE |
| 340 | SUPRAZIN-500 | Azithromycine | 500 mg | Comprimé | B/3 | Générique | CENTURION LABORATORIES PVT.LTD | India | SUPREME PHARMA HEALTHCARE PVT. LTD | India | ABREMA028ND2023 | 2023-03-17 | VALIDE |
| 341 | CARVEDI-DENK 6.25 | Carvedilol | 6,25 mg | comprimé | B/30 | Génerique | Artesan Pharma GmbH § Co. KG | Germany | DENK PHARMA GmbH & Co. KG | Germany | ABREMA028ND2022 | 2022-12-30 | VALIDE |
| 342 | LEVOPLANT | Levonorgestrel Silastic Implants | 75 mg | Implant | B/10x2 | Générique | Shanghai Dahua Pharmaceutical Co. Ltd. | China, People s Republic of | Shanghai Dahua Pharmaceutical Co. Ltd. | China, People s Republic of | ABREMA027ND2024 | 2024-03-06 | VALIDE |
| 343 | SPIREX PLUS | Spiramycine Métronidazole | 1.5 MUI 250 mg | Comprimé | Boite de 20 Comprimés | Générique | MEDICAL UNION PHARMACEUTICALS (MUP) | Egypt | MEDICAL UNION PHARMACEUTICALS (MUP) | Egypt | ABREMA027ND2023 | 2023-03-16 | VALIDE |
| 344 | Perinam Denk 8/10 mg | Périndopril terbutylamide Amlodipine besylate | 8 mg 10 mg | Comprimé | B/30 | Génerique | ACTAVIS LTD | Malta | DENK PHARMA GmbH & Co. KG | Germany | ABREMA027ND2022 | 2022-12-30 | VALIDE |
| 345 | NOGLUC | Glibenclamide | 5mg | Comprimé | Boite de 28 Cés | Générique | COSMOS LIMITED | Kenya | COSMOS LIMITED | Kenya | ABREMA026ND2024 | 2024-03-06 | VALIDE |
| 346 | Perinam Denk 8/5 mg | Périndopril terbutylamide Amlodipine besylate | 8 mg 5 mg | Comprimé | B/30 | Génerique | ACTAVIS LTD | Malta | DENK PHARMA GmbH & Co. KG | Germany | ABREMA026ND2022 | 2022-12-30 | VALIDE |
| 347 | Glumac | ARTEMETHER AND LUMEFANTRINE | 80 mg 480 mg | Comprimé | B/6x1 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA025ND2024 | 2024-03-06 | VALIDE |
| 348 | PALUCURE DT 20/120 | Artéméther Luméfantrine | 20 mg + 120 mg | Comprimé Dispersible | B/6 | Générique | M/S ASSOCIATED BIOTECH | India | RENA EXPORTS PVT LTD | India | ABREMA025ND2023 | 2023-03-16 | VALIDE |
| 349 | Perinam Denk 4/10 mg | Périndopril terbutylamide Amlodipine besylate | 4 mg 10 mg | Comprimé | B/30 | Génerique | ACTAVIS LTD | Malta | DENK PHARMA GmbH & Co. KG | Germany | ABREMA025ND2022 | 2022-12-30 | VALIDE |
| 350 | Glumac | ARTEMETHER AND LUMEFANTRINE | 80 mg 480 mg | Comprimé | B/6x30 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA024ND2024 | 2024-03-06 | VALIDE |
| 351 | OMESK | Oméprazole | 20 mg | Capsule | B/10x10 | Générique | S Kant HEALTHCARE Ltd. | India | S Kant HEALTHCARE Ltd. | India | ABREMA024ND2023 | 2023-03-16 | VALIDE |
| 352 | Perinam Denk 4/5 mg | Périndopril terbutylamide Amlodipine besylate | 4 mg 5 mg | Comprimé | B/30 | Génerique | ACTAVIS LTD | Malta | DENK PHARMA GmbH & Co. KG | Germany | ABREMA024ND2022 | 2022-12-30 | VALIDE |
| 353 | OXCIN-D | Moxifloxacin, Dexamethasone phosphate | 0,5 % w/v et 0,1 % w/v | solution ophtalmique | Flacon 5 ml | Générique | ATCO Laboratories LMD | Pakistan | ATCO Laboratories LMD | Pakistan | ABREMA023ND2024 | 2024-03-06 | VALIDE |
| 354 | MUCOLEX | Amboroxol Hydroxhloride Salbutamol Guaifenesine Le | 30 mg+1 mg+ 50 mg +0,5 mg/5 ml | Sirop | Flacon de 100 ml | Générique | S Kant HEALTHCARE Ltd. | India | S Kant HEALTHCARE Ltd. | India | ABREMA023ND2023 | 2023-03-16 | VALIDE |
| 355 | NODIAR | Diosmectite | 3 g | Poudre pour suspension buvable en sachet | B/30 | Générique | HAINAN SIMCERE PHARMACEUTICAL CO. , LTD | China, People s Republic of | B&O PHARMA | France | ABREMA023ND2022 | 2022-12-30 | VALIDE |
| 356 | BRIMODROP | Tartrate de Brimodine | 2mg/ml | Collyre en solution | Flacon de 5 ml | Génerique | RARARM.S.A | Greece | EXTENDIS PHARMA.S.L | Spain | ABREMA022ND2024 | 2024-03-06 | VALIDE |
| 357 | MAGNOMINT | Magnesium Trisilicate BP Hydroxyde d'Aluminium BP | 250 mg 125 mg | Comprimé | B/10x10 | Générique | REGAL PHARMACEUTICALS LTD | Kenya | REGAL PHARMACEUTICALS LTD | Kenya | ABREMA022ND2023 | 2023-03-16 | VALIDE |
| 358 | NODIAR | Diosmectite | 3 g | Poudre pour suspension buvable en sachet | B/10 | Générique | HAINAN SIMCERE PHARMACEUTICAL CO. , LTD | China, People s Republic of | B&O PHARMA | France | ABREMA022ND2022 | 2022-12-30 | VALIDE |
| 359 | TRAVODROP | Travoprost | 40mg/ml | Collyre en solution | Flacon de 5 ml | Génerique | RARARM.S.A | Greece | EXTENDIS PHARMA.S.L | Spain | ABREMA021ND2024 | 2024-03-06 | VALIDE |
| 360 | INFLACAM | Piroxicam | 20 mg | Comprimé dispersible | B/10 | Générique | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | ABREMA021ND2023 | 2023-03-16 | VALIDE |
| 361 | Resptol | Propionate de fluticasone Salméterol | 500µg 50µg | Poudre à inhaler | B/60 + 1 inhalateur | Générique | LABORATORIOS LICONSA, S.A | Spain | B&O PHARMA | France | ABREMA021ND2022 | 2022-12-30 | VALIDE |
| 362 | TINAZOL | Tinidazol | 500mg | Comprimé | Boite de 4Cp | Générique | Gracure pharmaceutical.Ltd | India | EXPHAR S.A | Belgium | ABREMA020RV2024 | 2024-12-31 | VALIDE |
| 363 | LUMERAX DT 20/120 | Artémether et Luméfantrine | 20mg/120mg | Comprimés dispersible | B/30x6 | Générique | IPCA Laboratories LTD | India | IPCA Laboratories | India | ABREMA020ND2024 | 2024-03-06 | VALIDE |
| 364 | IMMU-C | Extrait sec d'Echinacea Vitamine C Sulfate de Zinc | 200 mg 500 mg 35 mg | sachet | B/10, 5G | Générique | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | ABREMA020ND2023 | 2023-03-16 | VALIDE |
| 365 | Resptol | Propionate de fluticasone Salméterol | 250µg 50µg | Poudre à inhaler | B/60 + 1 inhalateur | Générique | LABORATORIOS LICONSA, S.A | Spain | B&O PHARMA | France | ABREMA020ND2022 | 2022-12-30 | VALIDE |
| 366 | LUMERAX DT 20/120 | Artémether et Luméfantrine | 20mg/120mg | Comprimés dispersible | B/30x1x12 | Générique | IPCA Laboratories LTD | India | IPCA Laboratories | India | ABREMA019ND2024 | 2024-03-06 | VALIDE |
| 367 | HUMODAR R 100 R | INSULINE HUMAINE RECOMBINANTE | 100 UI/ml | Suspension injectable | Flacon de 10 ml | Générique | PrJSC "INDAR | Ukraine | PrJSC "INDAR | Ukraine | ABREMA019ND2023 | 2023-03-16 | VALIDE |
| 368 | Resptol | Propionate de fluticasone Salméterol | 100µg 50µg | Poudre à inhaler | B/60 + 1 inhalateur | Générique | LABORATORIOS LICONSA, S.A | Spain | B&O PHARMA | France | ABREMA019ND2022 | 2022-12-30 | VALIDE |
| 369 | LUMERAX DT 20/120 | Artémether et Luméfantrine | 20mg/120mg | Comprimés dispersible | B/30x1x6 | Générique | IPCA Laboratories LTD | India | IPCA Laboratories | India | ABREMA018ND2024 | 2024-03-06 | VALIDE |
| 370 | HUMODAR C25 100 R | INSULINE HUMAINE RECOMBINANTE | 100 UI/ml | Suspension injectable | Flacon de 10 ml | Générique | PrJSC "INDAR | Ukraine | PrJSC "INDAR | Ukraine | ABREMA018ND2023 | 2023-03-16 | VALIDE |
| 371 | Cholvat | Atorvastatine calcium trihydrate | 40 mg | Comprimé pelliculé | B/30 | Générique | LABORATORIOS LICONSA, S.A | Spain | B&O PHARMA | France | ABREMA018ND2022 | 2022-12-30 | VALIDE |
| 372 | LUMERAX DT 20/120 | Artémether et Luméfantrine | 20mg/120mg | Comprimés dispersible | B/30X12 | Générique | IPCA Laboratories LTD | India | IPCA Laboratories | India | ABREMA017ND2024 | 2024-03-06 | VALIDE |
| 373 | HUMODAR B 100 R | INSULINE HUMAINE RECOMBINANTE | 100 UI/ml | Suspension injectable | Flacon de 10 ml | Générique | PrJSC "INDAR | Ukraine | PrJSC "INDAR | Ukraine | ABREMA017ND2023 | 2023-03-16 | VALIDE |
| 374 | Cholvat | Atorvastatine calcium trihydrate | 20 mg | Comprimé pelliculé | B/30 | Générique | LABORATORIOS LICONSA, S.A | Spain | B&O PHARMA | France | ABREMA017ND2022 | 2022-12-30 | VALIDE |
| 375 | PROSTALEN | CHLORHYDRATE D'ALFUZOSINE | 10 MG | Comprimé LP | B/30 compriés | Générique | Gracure Pharmaceuticals Limited | India | EXPHAR S.A | Belgium | ABREMA016ND2024 | 2024-03-06 | VALIDE |
| 376 | GULEPRIL | Glimépiride | 2 mg | Comprimé | B/12x2 | Générique | WANBAG BIOPHARMACEUTICALS | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA016ND2023 | 2023-03-16 | VALIDE |
| 377 | SKDERM CREAM | Bétamethasone Dipropionate Clotrimazole Gentamici | 0,05% w/w + 1,0% w/w +0,1% w/w | Crème | T/15 G | Générique | S Kant HEALTHCARE Ltd. | India | S Kant HEALTHCARE Ltd. | India | ABREMA016ND2023 | 2023-03-16 | VALIDE |
| 378 | CLONEM | Clotrimazole | 0.01 | Crème | T/20G | Générique | NEM LABORATORIES PVT LTD | India | NEM LABORATORIES PVT LTD | India | ABREMA016ND2022 | 2022-12-30 | VALIDE |
| 379 | DIFENASOL | DICLOFENAC SODIQUE | 0,1% | Collyre | Flacon 5 ml | Générique | Ahlcon Parenterals Ltd | India | EXPHAR S.A | Belgium | ABREMA015ND2024 | 2024-03-06 | VALIDE |
| 380 | GUAFLEX® SYRUP | Extrait de feuilles de goyave Extrait de felurs de | 6ml+6ml+ 0,12ml/120 ml | Sirop | Flacon de 120 ml | Générique | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | ABREMA015ND2023 | 2023-03-16 | VALIDE |
| 381 | TIGBODERM® G-CREAM | Betamethasone dipropionate Clotrimazole Gentamicin | 0,05% 1% 0.1% | Crème | T/30G | Générique | NEM LABORATORIES PVT LTD | India | NEM LABORATORIES PVT LTD | India | ABREMA015ND2022 | 2022-12-30 | VALIDE |
| 382 | IXINE | Cefixime | 200 mg | comprimé pellicullé | B/10 | Générique | GRACURE PHARMACEUTICALS LIMITED | India | EXPHAR S.A | India | ABREMA014ND2024 | 2024-03-06 | VALIDE |
| 383 | Glumac | ARTEMETHER AND LUMEFANTRINE | 20 mg 120 mg | Comprimé | B/24 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA014ND2023 | 2023-03-16 | VALIDE |
| 384 | TRANGEL ULTRA | Diclofenac diéthylamine Methyl salicylate Methol | 10 mg 80 mg 60 mg 0,15 mg | gel | T/20G | Générique | NEM LABORATORIES PVT LTD | India | NEM LABORATORIES PVT LTD | India | ABREMA014ND2022 | 2022-12-30 | VALIDE |
| 385 | IXINE | Cefixime | 40mg/ 5ml | PPSO | Flacon de 40 ml | Générique | GRACURE PHARMACEUTICALS LIMITED | India | EXPHAR S.A | Belgium | ABREMA013ND2024 | 2024-03-06 | VALIDE |
| 386 | Glumac | ARTEMETHER AND LUMEFANTRINE | 20 mg 120 mg | Comprimé | B/18 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA013ND2023 | 2023-03-16 | VALIDE |
| 387 | CIPRO 0,3% | Ciprofloxacine Chlorhydrate | 0.003 | Collyre | Flacon de 5 ml | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA013ND2022 | 2022-10-14 | VALIDE |
| 388 | IXINE | Cefixime | 100m/5ml | PPSO | Flacon de 40 ml | Générique | GRACURE PHARMACEUTICALS LIMITED | India | EXPHAR S.A | Belgium | ABREMA012ND2024 | 2024-03-06 | VALIDE |
| 389 | Glumac | ARTEMETHER AND LUMEFANTRINE | 20 mg 120 mg | Comprimé | B/12 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA012ND2023 | 2023-03-16 | VALIDE |
| 390 | ATRACURIUM MEDIS 50 | ATRACURIUM BESYLATE | 50 mg | Solution injectable | Flacon de 5 ml, B/50 | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA012ND2022 | 2022-10-14 | VALIDE |
| 391 | Glumac | ARTEMETHER AND LUMEFANTRINE | 20 mg 120 mg | Comprimé dispersible | B/6 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA011ND2023 | 2023-03-16 | VALIDE |
| 392 | ATRACURIUM MEDIS 25 | ATRACURIUM BESYLATE | 25mg | Solution injectable | Flacon de 2,5 ml, B/50 | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA011ND2022 | 2022-10-14 | VALIDE |
| 393 | CLOFAINS | DICLOFENAC SODIQUE +PARACETAMOL | 50mg, 500mg | Comprimé | B/10 comprimés | Générique | MILAN LABORATORIES (INDIA) PVT.LTD | India | EXPHAR S.A | Belgium | ABREMA010ND2024 | 2024-03-06 | VALIDE |
| 394 | FLEXPRO EXTRA | Methocarbamol Paracetamol | 400 mg 500 mg | Comprimé pelliculé | B/20 | Générique | MEDICAL UNION PHARMACEUTICALS (MUP) | Egypt | MEDICAL UNION PHARMACEUTICALS (MUP) | Egypt | ABREMA010ND2023 | 2023-03-16 | VALIDE |
| 395 | Depo-Provera | Acétate de médroxyprogestérone | 150 mg/ml | Suspension injectable | B/25 | Pfizer Global Pharmaceuticals | Cote d Ivoire (Ivory Coast) | Pfizer Global Pharmaceuticals | Cote d Ivoire (Ivory Coast) | ABREMA010ND2022 | 2022-10-14 | VALIDE | |
| 396 | Depo-Provera | Acétate de médroxyprogestérone | 150mg/ml | Solution injectable | B/25 | EXPHAR s.a | Belgium | Pfizer Global Pharmaceuticals | Cote d Ivoire (Ivory Coast) | ABREMA010ND2022 | 2022-10-14 | VALIDE | |
| 397 | NEOMDEXSOL | PHOSPHATE SODIQUE de Dexaméthasone + SULFATE DE N | 0,1% , 0,35% | Collyre | Flacon 5mg, 1 ml | Générique | Ahlcon Parenterals Ltd | India | EXPHAR S.A | Belgium | ABREMA009ND2024 | 2024-03-06 | VALIDE |
| 398 | DISTEM | Methocarbamol Paracetamol | 380 mg 300 mg | Comprimé | B/50 | Générique | FAES FARMA, S.A | Spain | FAES FARMA, S.A | Spain | ABREMA009ND2023 | 2023-03-16 | VALIDE |
| 399 | DERMOBACTER | Chlorure de benzalkonium/digluconate de chlorhexid | 500mg, 200mg | Solution pour application cutanée | Flacon/300ml | Générique | INNOTHERA CHOUZY | France | LABORATOIRE INNOTECH INTERNATIONAL | France | ABREMA009ND2022 | 2022-10-14 | VALIDE |
| 400 | MAXIM 400 | Moxifloxacine | 400mg | Antibiotiques | Boite/5 comprimés | Générique | JAMJOON PHARMACEUTICALS FACTORY | Saudi Arabia | JAMJOON PHARMACEUTICALS FACTORY | Saudi Arabia | ABREMA008ND2024 | 2024-03-06 | VALIDE |
| 401 | DIP-3 | Dihydroartemisinine + Piperaquine Phosphate | 40 mg + 320 mg | Comprimé | B/1x9 | Générique | M/S ASSOCIATED BIOTECH | India | RENA EXPORTS PVT LTD | India | ABREMA008ND2023 | 2023-03-16 | VALIDE |
| 402 | PIROXEN | Piroxicam | 20 mg | Comprimé dispersible | B/12 | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA008ND2022 | 2022-10-14 | VALIDE |
| 403 | SHAL'ARTEM | Artéméther Luméfantrine | 20 mg 120 mg | Comprimé | B/24 | Générique | SHALINA LABORATORIES PVT.LTD | India | M/s SHALINA HEALTHCARE DMCC | United States | ABREMA007ND2024 | 2024-03-06 | VALIDE |
| 404 | DIASTOP | Calcium carbonate Kaolin Catechu tincture Bellado | 8 mg+8 mg+15ml+2 ml+0,2ml+1ml/100ml | Sirop | Flacon de 60 ml | Générique | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | ABREMA007ND2023 | 2023-03-16 | VALIDE |
| 405 | Allercol | Chlorpheniramine maléate | 2 mg/5ml | Sirop | Flacon de 60 ml | Générique | NJIMIA(K) LIMITED | Kenya | NJIMIA(K) LIMITED | Kenya | ABREMA007ND2022 | 2022-10-14 | VALIDE |
| 406 | TEFOVIR PHARMA 5 | Tenofovir disoprosil fumarate | 300mg | Comprimé pelliculé | B/30 | Générique | LABORATOIRES PHARMA 5 | Morocco | LABORATOIRES PHARMA 5 | Morocco | ABREMA006ND2024 | 2024-03-06 | VALIDE |
| 407 | DEFAL | Déflazacort | 22,75 mg/ml | Goutte buvable | Flacon de 13 ml | Princeps | FAES FARMA, S.A | Spain | FAES FARMA, S.A | Spain | ABREMA006ND2023 | 2023-03-16 | VALIDE |
| 408 | BUTO-ASMA | Salbutamol | 100 mcg | aérosol | 200 doses | Générique | Laboratorio Aldo-Union,S.L | Spain | Laboratoire Aldo-Union,SL | Spain | ABREMA006ND2022 | 2022-09-01 | VALIDE |
| 409 | SSB 400 | Sofosbuvir | 400mg | comprimé pelliculé | B/28 | Générique | LABORATOIRES PHARMA 5 | Morocco | LABORATOIRES PHARMA 5 | Morocco | ABREMA005ND2024 | 2024-03-06 | VALIDE |
| 410 | CHONDROGEN | Chondroitine sulfate sodique Glucosamine sodique | 400 mg 500 mg | Comprimé | B/2x10 | Générique | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | ABREMA005ND2023 | 2023-03-16 | VALIDE |
| 411 | TRAMADIS | Tramadol Chlorhydrate | 50 mg | Comprimé | B/10 | Générique | LES LABORATOIRES MEDIS | Tunisia | LES LABORATOIRES MEDIS | Tunisia | ABREMA005ND2022 | 2022-10-14 | VALIDE |
| 412 | BETASTENE | Betaméthasone | 2mg | Comprimé dispersible | B/20 | Générique | LABORATOIRES PHARMA 5 | Morocco | LABORATOIRES PHARMA 5 | Morocco | ABREMA004ND2024 | 2024-03-06 | VALIDE |
| 413 | BRONCHO®SYRUP | Lobellia tincture Scilla tincture Liquorice Extrac | 0,5ml+0,15ml+1ml+0,15 ml/5 ml | Sirop | Flacon de 120 ml | Générique | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | Arab Company for Pharmaceuticals & Medicinal Plant | Egypt | ABREMA004ND2023 | 2023-03-16 | VALIDE |
| 414 | Glumac | Artéméther Luméfantrine | 20 mg 120 mg | Comprimé | B/24 X30 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA004ND2022 | 2022-09-01 | VALIDE |
| 415 | BETASTENE | Betaméthasone | 0.0005 | solution buvable en goutte | Flacon de 30ml | Générique | LABORATOIRES PHARMA 5 | Morocco | LABORATOIRES PHARMA 5 | Morocco | ABREMA003ND2024 | 2024-03-06 | VALIDE |
| 416 | AQUANATE -60 | Artesunate | 60 mg | Pudre pour injection | Flacon de 7,5 ml | Générique | M/S RENA EXPORTS PVT.LTD. | India | RENA EXPORTS PVT LTD | India | ABREMA003ND2023 | 2023-03-16 | VALIDE |
| 417 | Glumac | Artéméther Luméfantrine | 20 mg 120 mg | Comprimé | B/18 X30 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA003ND2022 | 2022-09-01 | VALIDE |
| 418 | ASTAPH | Flucloxacilline | 500mg | gélule | B/24 | Générique | LABORATOIRES PHARMA 5 | Morocco | LABORATOIRES PHARMA 5 | Morocco | ABREMA002ND2024 | 2024-03-06 | VALIDE |
| 419 | A-CERUMEN | Acyl sarcosinate de sodium Laurate de saccharose | 15,00 % 5,00 % | Spray auriculaire | Flacon de 40 ml | Princeps | LABORATOIRES GILBERT | France | LABORATOIRES GILBERT | France | ABREMA002ND2023 | 2023-03-16 | VALIDE |
| 420 | Glumac | Artéméther Luméfantrine | 20 mg 120 mg | Comprimé | B/12 X30 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA002ND2022 | 2022-09-01 | VALIDE |
| 421 | ASTAPH | Flucloxacilline | 500mg | gélule | B/12 | Générique | LABORATOIRES PHARMA 5 | Morocco | LABORATOIRES PHARMA 5 | Morocco | ABREMA001ND2024 | 2024-03-06 | VALIDE |
| 422 | A-CERUMEN | Acyl sarcosinate de sodium Laurate de saccharose | 15,00 % 5,00 % | Solution aurucilaire | Flacon de 2 ml, B/10 | Princeps | LABORATOIRES GILBERT | France | LABORATOIRES GILBERT | France | ABREMA001ND2023 | 2023-03-16 | VALIDE |
| 423 | Glumac | Artéméther Luméfantrine | 20 mg 120 mg | Comprimé dispersible | B/6 X30 | Générique | GUILIN PHARMACEUTICAL CO. LTD | China, People s Republic of | SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO. LTD | China, People s Republic of | ABREMA001ND2022 | 2022-09-01 | VALIDE |
Copyright © 2025 L’Autorité Burundaise de Régulation des Médicaments à usage humain et des Aliments - All rights reserved